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CHAPTER 1 
RATIONALE 

1 
Rationale 
Blood pressure rises sharply from infancy through adolescence. About two thirds of the 
total lifetime increase in systolic blood occurs in childhood. Throughout adult life, the 
rise in blood pressure with age continues slowly but steadily. Whereas the mean diastolic 
blood pressure level seems to decline after the age of 55, systolic blood pressure increases 
even further at older age (fig. 1.1). 
The age-related rise in blood Iiressure has hardly been observed in populations with a 
low sodium and high potassium intake, which gave rise to the hypothesis that these 
electrolytes could be implicated in the aetiology of hypertension. However, most 
observational studies within single populations could not confirm the relationship between 
dietary sodium and potassium intake and blood pressure. The lack of an association has 
often been attributed to inaccurate assessment of electrolyte intakes or blood pressure, or 
to the restricted ranges of intakes within a single population. An alternative explanation, 
however, could be that a population consists of a heterogeneous group of individuals, 
whose blood pressures may react quite differently to dietary influences. Evidence is now 
Figure 1.1 Mean level of systolic and diastolic blood pressure at young and old age. * 
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* Data have been obtained from a study among 476 Dutch neonates (Hofman A, el al., JAMA 
1983;250:370-3) and from a cross sectional study among 10,355 subjects in the Netherlands (Va1kenburg 
HA, et al. Ned Tijdschr Geneeskd 1980; 124:183-9), Used with permission of the authors and publishers. 
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accumulating that there are subgroups that are susceptible to the intake of electrolytes, 
and others that are not. The sensitivity of blood pressure to electrolytes, in particular to 
sodium, may vary during life, During infancy, a high sodium intake could harmfully 
affect the immature kidney tissue, thereby having an influence on the natriuresis setpoint 
and the development of blood pressure in the years thereafter, At older age, the ability of 
the kidney to excrete sodium is reduced and the renin-angiotensin system becomes less 
responsive, which may increase the susceptibility of blood pressure to a higher intake of 
salt. 
This thesis focuses on the relation between electrolyte intake and blood pressure during 
two phases in life that seem of particular importance in view of the sodium-blood pressure 
association, namely childhood and old age. Because the renal handling of sodium and 
potassium is closely related, the associations of these electrolytes with blood pressure 
were concomitantly considered in most of the studies described in this thesis. The role of 
neonatal sodium intake in determining blood pressure 15 years later in life is reported in 
Chapter 2. Chapter 3 describes the role of dietary sodium, potassium, and sodium! 
potassium ratio in determining the rise in blood pressure from childhood into adulthood, 
using long-term follow-up data of a young subcohort drawn from a large Dutch 
population study (EPOZ). In Chapters 4.1 and 4.2 the association between electrolyte 
intake and blood pressure at old age was investigated cross sectionally within the cohort 
of the Rotterdam Study, a population based study among men and women aged 55 and 
over. Subsequently, a double blind, randomised, multifactorial intervention trial was 
conducted to see whether moderate dietary sodium restriction, combined with potassium 
and magnesium supplementation, would reduce blood pressure in older people with mild 
to moderate hypertension (Chapter 4.3). Some studies have pointed towards a potential 
unfavourable effect of sodium restriction on the blood lipid profile. In Chapter 4.4 we 
investigated whether this was also the case in our study. The findings of the presented 
studies are discussed and new research areas are delineated in Chapter 5. 
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CHAPTER 2 
LONG-TERM EFFECTS OF NEONATAL SODIUM 
RESTRICTION ON BLOOD PRESSURE 

2 
Long-term effects of neonatal sodinm restriction on blood pressure 
Introdnction 
Despite extensive research, the causes of the epidemic of high blood pressure in 
westernised societies remain largely unknown. Population studies indicate that primary 
hypertension has its roots in childhood. '.2.3 It has been shown that blood pressure levels 
in infancy and childhood are moderately predictive for blood pressure later in life.""· 
Consequently, determinants of blood pressure in early life could be important in relation 
to future hypertension. 
In a randomised, double blind trial among 476 newborn Dutch infants conducted in 
1980, sodium intake was positively related to blood pressure during the first six months 
of life.' In the present analysis we investigated whether contrasting levels of sodium 
intake in infancy are still associated with blood pressure differences later in life. For this 
purpose, blood pressure in 167 youngsters who had participated in the original trial was 
measured again after 15 years of follow-up. In addition, possible modification of the 
effect of sodium on blood pressure by sex, body mass index and resting heart rate was 
investigated. 
Methods 
Sodilllll-blood presslIre trial 
A group of 476 newborn infants participated in a randomised double blind trial of the 
effect of sodium intake on blood pressure. All infants were born in 1980 to healthy 
women living in Zoetermeer, The Netherlands. Two hundred and thirty-one infants were 
randomly assigned to a low sodium diet and 245 infants to a normal sodium diet during 
the first six months of life. Systolic blood pressure was measured in the first week of life 
and every 4 weeks thereafter using a Doppler ultrasound device connected to a random-
zero sphygmomanometer. Diastolic blood pressure could not be recorded accurately by 
this procedure. A detailed description of the study protocol has been given previously.' 
The average daily amount of sodium (± SD) consumed during the trial amounted to 
0.89 ± 0.26 moles in the low sodium group and 2.50 ± 0.95 moles in the normal 
sodium group. After 25 weeks of intervention, systolic blood pressure in the low sodium 
group was 2.1 nunHg lower (90% CI 0.5 to 3.7, p,=O.OI) than in the normal sodium 
group after adjustment for weight and length at birth, systolic blood pressure in the first 
week, and blood pressure observers. 
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Subjects for the follow-up study 
A total of 466 infants (98%) completed the trial and were eligible for the present follow-
up study. The current addresses of 185 children could not be traced. Seventy-one children 
had moved out of Zoetermeer and they were not invited for logistic reasons. Eleven 
children could not be contacted by telephone. A total of 199 children was contacted (45 % 
of those eligible). Twelve children refused participation.' Twenty children could not 
participate because of illness, holiday, or other activities. A total of 167 children (84% of 
those contacted) agreed to participate and they visited the study centre for blood pressure 
measurements. Of those, 71 children had initially been assigned to the low sodium group, 
and 96 children to the normal sodium group. 
Follow-up measurements 
Blood pressure and heart rate were measured on the right arm by two investigators, using 
an automatic device (Dinamap model 8100, Critikon Inc, Florida) while the participant 
was seated. After at least five minutes rest, four measurements were perfonned of which 
the last three were averaged. Body weight and height were measured without heavy 
clothing and shoes. The body mass index was computed as weight divided by height 
squared. During the visit at the study centre, information was obtained by means of a 
questionnaire on current use of medication, smoking, consumption of alcohol, physical 
activity (sports, biking and walking), education, presence of treated hypertension in 
parents (yes/no), and age at menarche. The educational level of the participants was rated 
on a 5-point scale and subsequently recoded to three levels (low, average or high 
education). The educational level of the parents, which had been assessed on a 9-point 
scale at the start of the trial, was also reduced to three levels. The participants collected 
an overnight urine specimen after visiting the study centre. The time of collection and 
urinary volume were recorded. Urinary sodium, potassium and creatinine were analysed 
by standard laboratory methods. The overnight urinary excretions of sodium and 
potassium were standardised to 24 hour values. 
Data analysis 
The present study population was regarded as a cohort with two different levels of 
(experimentally manipulated) sodium intake early in life. The exposure was based on the 
initial randomization code, irrespective of subsequent protocol deviations or compliance. 
The difference in blood pressure between the study groups after 15 years of follow-up 
was computed and tested for statistical significance by means of a two-tailed unpaired t 
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test. The loss to follow-up of subjects for the present study, although for reasons 
unrelated to the object of research, introduced unequal distributions of baseline and 
current characteristics between the study groups. Therefore, an additional analysis was 
performed to adjust for potential confounders. A multiple linear regression model was 
used with systolic and diastolic blood pressure as the outcome variables. Adjustments 
were made for sex, length and weight at birth, maternal educational level, maternal 
systolic blood pressure at baseline, educational level of the participant, presence of treated 
hypertension in parents and blood pressure observers. An indicator for the sodium group 
(O=low, 1 =norrnal) was entered as an independent variable. The regression coefficient 
Table 2.1 Baseline characteristics of the follow-up cohort according to study group (n= 167). 
Normal sodium Low sodium 
(n=96) (n=71) 
Sex ratio (% M/F) 50/50 54/46 
Length at birth (cm) 50.9 (2.0) 51.5 (1.7) * 
Weight at birth (g) 3406 (422) 3583 (405) t 
Systolic blood pressure (nunHg) 8604 (21.4) 88.2 (20.1) 
Heart rate (beats/min) 69.1 (9.7) 69.8 (10.0) 
Duration of pregnancy (weeks) 39.7 (1.2) 40.0 (1.2) 
Blood pressure father (mmHg): 
Systolic 125.1 (lOA) 126.7 (13.7) 
Diastolic 79.8 (11.6) 80.7 (14.7) 
Blood pressure mother (mmHg): 
Systolic !I 1.6 (10.7) !l4.7 (10.0) + 
Diastolic 7004 (11.5) 73.2 (10.1) 
Educational level father (%): 
Low 25 38 
Average 25 21 
High 50 41 
Educational level mother (%): 
Low 22 48 
Average 45 27 
High 33 25 § 
Values are means with standard deviation in parentheses, or percentages. 
* .=1.94, p,=O.05; t .=2.74, p,=O.OO7; * t=1.91, p,=O.06; § X'"",=19.1, p,=O.015. 
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for the sodium group yielded by this model estimates the adjusted blood pressure 
difference between the sodium groups. The analyses were repeated for boys and girls 
separately and in strata of body mass index and resting heart rate. Stratification for body 
mass index and heart rate was performed by dividing the persons into two groups 
according to the sex-specific medians of the distributions. The differences in blood 
pressure are given with a 95 % confidence interval and a two-sided p-value. 
Results 
Baseline characteristics of the follow-up cohort are given in table 2.1. A larger proportion 
of boys was observed in the low sodium group than in the normal sodium group, but the 
difference was not statistically significant. Length and weight at birth were significantly 
higher in the low sodium group than in the normal sodium group. Furthermore, mothers 
were significantly lower educated and maternal systolic blood pressure tended to be 
higher in the low sodium group. Other baseline characteristics were similar in the two 
groups. 
Characteristics of the participants after 15 years of follow-up are given in table 2.2. No 
significant differences in height, body weight, body mass index and physical activity were 
observed between the study groups. Frequencies of smoking and consumption of alcohol 
were similarly distributed in both groups. Significantly more participants in the low 
sodium group than in the normal sodium group reported to have one parent currently 
treated for hypertension. None of the participants had both parents currently treated for 
hypertension. Participants in the low sodium group were significantly lower educated than 
those in the normal sodium group. Among girls, the age at menarche was not 
significantly different between the groups. 
Table 2.3 shows the differences in blood pressure between the study groups after 15 
years of follow-up. Systolic and diastolic blood pressure levels were slightly higher in the 
normal sodium group than in the low sodium group, but the differences were not 
statistically significant. After adjustment for potential confounders (indicated in table 2.3), 
systolic blood pressure was 3.6 mmHg higher (95% CI 0.5 to 6.6 mmHg, Pl=0.02) and 
diastolic blood pressure was 2.2 mmHg higher (95% CI -0.2 to 4.5 mmHg, Pl=0.08) in 
the normal sodium group than in the low sodium group. The change in regression 
coefficients after adjustment was attributable to the inclusion of length and weight at 
birth, maternal educational level, maternal systolic blood pressure, and presence of 
treated hypertension in parents, in the multivariate model. A small additional change was 
observed after further adjustment for educational level of the participant, sex, and blood 
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Table 2.2 Current characteristics of the follow-up cohort according to study group (n= 167). 
Normal sodium Low sodium 
(11=96) (11=71) 
Height (cm) 170.9 (8.5) 171.9 (8.4) 
Body weight (kg) 59.0 (11.0) 59.8 (9.9) 
Body mass index (kg/m') 20.1 (2.7) 20.2 (2.8) 
Systolic blood pressure (l1llI1Hg) 117.5 (10.6) 116.1 (10.5) 
Diastolic blood pressure (mmHg) 56.4 (7.8) 55.8 (7.7) 
Heart rate (beats/min) 77.0 (10.9) 81.2 (11.6) * 
Physical activity (hrs/week) 7.8 (4.8) 6.7 (3.8) 
Age at menarche (yrs) 12.8 (1.2) 12.5 (1.1) 
Smoking (%) 9 9 
Alcohol consumption (%) 13 11 
Hypertension in father or mother (%) 8 18 t 
Educational level: 
Low 17 30 
Average 36 41 
High 47 29 + 
Urinary excretion (mmol/24h): 
Sodium 85 (46) 75 (31) 
Potassium 29 (16) 25 (10) 
Sodium/potassium ratio 3.4 (1.7) 3.3 (1.5) 
Creatinine 11.2 (4.3) 11.4 (3.4) 
Values are means with standard deviation in parentheses, or percentages. 
* t=2.4, p,=O.017; t X'=3.7, p,=O.05; + X1tteaj =12.1. Pl=O.016. 
pressure observers, whereas no change in regression coefficients was observed after 
adjustment for baseline systolic blood pressure. Differences in sodium and potassium 
excretion between the study groups were small and inclusion of these variables in the 
model (with or without correction for creatinine excretion) did not change the results. 
The effect of sodium on blood pressure did not differ significantly between boys and 
13 
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Table 2.3 Differences in blood pressure (BP) level between the normal sodium and low sodium 
group after 15 years of follow-up. 
Systolic BP (nunHg) Diastolic BP (nuuHg) 
Difference 1.5 (-1.8, 4.7) p~0.38 0.6 (-1.8, 3.0) p~O.61 
Adjusted difference* 3.6 (0.5, 6.6) p~O.02 2.2 (-0.2, 4.5) p~O.08 
Values are mean differences (normal minus low sodium group) with 95% confidence interval in parentheses 
and two-sided p-value. 
* Adjusted for sex, length and weight at birth, education, hypertension in parents, maternal education, 
maternal systolic blood pressure, and blood pressure observers. 
girls, or between subjects with a body mass index below and above the median of the 
distribution. When the analysis was restricted to persons with a resting heart rate above 
the median, the adjusted differences in blood pressure between the sodium groups were 
6.0 mmHg (95% CI 1.5 to 10.5 mmHg, p,=O.OI) for systolic blood pressure, and 4.8 
mmHg (95% CI 0.9 to 8.7 mmHg, p,=0.02) for diastolic pressure. In persons with a 
resting heart rate below the median, differences in blood pressure were small (-0.8 mmHg 
and -1.7 mmHg for systolic and diastolic blood pressure, respectively) and not statistically 
significant. 
Discllssion 
This paper presents the results of a long-term follow-up of a cohort of children who had 
been exposed to contrasting levels of sodium intake during the first six months of life. 
The findings show that sodium intake in infancy is associated with systolic and diastolic 
blood pressure 15 years later in life, after adjustment for confounders. The blood pressure 
effect of sodium appears to be modified by resting heart rate. 
The children remeasured for the present analysis forms a subgroup of the original 
population that participated in a double-blind randomised trial of low VS. normal sodium 
intake. 7 As such, the study is a cohort study in which the contrast in baseline exposure, 
i.e. neonatal sodium intake, has been experimentally achieved. Forty percent of the 
subjects initially assigned to the normal sodium group, and 31 % of the subjects in the low 
sodium group, participated in the follow-up study. Whereas the study groups in the 
original trial were similar with regard to length and weight at birth, maternal systolic 
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blood pressure and maternal educational level, these variables differed between the 
sodium groups in the follow-up study. Furthermore, in the present study, subjects in the 
low sodium group were lower educated and reported more often current treatment for 
hypertension in one of the parents. These observed differences could be related to the 
change in blood pressure during childhood. Systolic blood pressure of the mother at the 
start of the study, for example, appeared to be positively associated with the blood 
pressure of the child 15 years later. Because maternal blood pressure at baseline was 
higher in the low sodium group than in the normal sodium group, the intervention-related 
difference in blood pressure levels at follow-up was reduced. In order to reliably esthnate 
the true effect of neonatal sodium intake on future blood pressure, the analyses were 
repeated using a multivariate model that included all potential confounders. The 
conclusions of the present study are based on the adjusted blood pressure differences. 
We cannot infer from our rmdings which mechanism has led to higher blood pressures 
in the normal sodium group. Possibly, the preference for a certain level of salt intake is 
determined early in life. Subjects in the present study who had been exposed to lower 
sodium intakes during infancy may have maintained a reduced salt intake after the trial, 
eventually resulting in lower blood pressure levels. The overnight excretion of sodium in 
the low sodium group indeed tended to be reduced compared to the normal sodium group. 
However, urinary potassium, which is inversely related to blood pressure and probably a 
stronger predictor of blood pressure change in childhood than sodium,' was also lower in 
these children. As only a single overnight urine spechnen for the assessment of sodium 
was collected at the time of the follow-up measurements, we cannot make a firm 
statement about salt intake during the preceding period. Several alternative explanations 
for the blood pressure difference can be given. Sympathetic nervous system overactivity 
may be related to essential hypertension through a sustained increase in peripheral 
vascular resistance. 9 A possible interaction between salt intake and the sympathetic 
nervous system in determining blood pressure level has been suggested. IO•11 In the 
present study, the blood pressure effect appeared to be restricted to those with higher 
resting heart rates. Staessen et at., in a population study, shnilarly found a significant 
positive association between 24 hour urinary sodium and blood pressure in subjects with 
high heart rates, whereas an opposite tendency was observed in persons with lower heart 
rates.1O An interaction between a high dietary sodium intake, envirorunental stress, and 
sympathetic neural control of renal function as part of the early hypertensive process has 
also been reported." Furthermore, exposure to high sodium levels in infancy may cause 
damage of the umnature kidney tissue and adversely affect the development of blood 
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pressure during growth and maturation. 13 An alternative explanation for the higher blood 
pressure levels in the normal sodium group could be an alteration in renal sodium 
handling, resulting from early changes in renal haemodynamics. In line with this 
hypothesis, an increased renal vasoconstriction and a decreased renin and aldosterone 
secretion has been observed in young offspring of hypertensive parents." 
Environmental exposures ill utero and in infancy may be more important in relation to 
cardiovascular disease than exposures in adulthood, as 'programming' of different systems 
and organs in the body may take place very early in life. IS Evidence is accumulating that 
birth weight is inversely related to the risk of hypertension later in life. I •• 17•I'.I, The 
present study suggests that neonatal sodium intake could be related to blood pressure level 
in adolescence. Data on the effect of nutrient intake in infancy on future blood pressure 
are scarce. Studies in this field may provide clues for the prevention of hypertension in 
westernised societies, and a further understanding of its causes. 
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CHAPTER 3 
ELECTROLYTES AND BLOOD PRESSURE 
AT YOUNG AGE 
THE EPOZ STUDY 

3.1 
Sodium and potassium intake and blood pressure change in childhood 
Introduction 
Primary hypertension is one of the most important risk factors for cardiovascular disease 
and probably has its onset in the first decades of life. Study of blood pressure in 
childhood may shed light on the aetiology of hypertension and indicate opportunities for 
measures to prevent hypertension in adult life. I Blood pressure in children is determined 
by genetic and enviromnental factors. Race, sex, and anthropometric characteristics such 
as height and body weight have been identified as determinants of blood pressure and the 
rise in childhood.''>'' Although the effect of biological maturation is still a subject of 
debate, alterations in growth and sex hormones may also be related to changes in blood 
pressure.s 
The part played by dietary factors has been thoroughly studied. Sodium intake has been 
the main topic, but most studies have been concerned with adults. Findings in some but 
not all interpopulation studies suggest that the prevalence of hypertension is lower in areas 
with a low sodium intake, although considerable doubt remains about the nature and 
significance of this. 6 In children and young adults findings are even less consistent. 7 
Moreover, the rise in blood pressure with age might to some extent be dependent on the 
average level of sodium intake in a popUlation. Recently the INTERSALT Co-operative 
Research Group found an additional rise in systolic blood pressure of 0.003 mmHg with a 
sodium intake that was on average 1 mmoll24h higher in adults.' If such an effect of the 
diet was already acting in childhood and persisted over a lifetime the consequences for the 
incidence of hypertension in a population might be substantial.' An inverse association of 
blood pressure with potassium has been noted occasionally, although this fmding remains 
controversial. lO Moreover, there may be an interaction among various dietary 
electrolytes. In particular, the sodium/potassium ratio could be important. 
Because advice on diet may well play a part in intervention, studies on the effect of 
dietary components on blood pressure remain important. In this study children with high 
intakes of sodium and potassium were compared with those having low intakes with 
regard to their individual changes in blood pressure over time. Change in blood pressure 
rather than actual blood pressure in children may be a predictor of adult blood pressure 
and of hypertension. II •12 
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Methods 
Population 
Between 1975 and 1978 the total population aged 5 years and over in two districts of 
Zoetenneer, a suburban town in the western part of the Netherlands, was invited to take 
part in a study of risk factors for cardiovascular disease.'" Of 5,670 eligible subjects aged 
5-19 years, 4,649 (82%) were examined. From this group a random sample of 596 
children was selected for annual follow-up in a study of blood pressure tracking and its 
detenninantsY They were examined four weeks after the initial examination and 
subsequently at yearly intervals. Children with established secondary hypertension were 
excluded. For the present analysis we selected children aged up to 17 at entry into the 
study and whose follow-up included at least six yearly examinations. Of the 233 subjects 
in the cohort, 108 were boys and 125 girls. The mean follow-up period was seven years. 
Measurements 
Blood pressure measurements were perfonned with a random zero sphygmomanometer as 
described in detail elsewhere.' Paramedical workers were trained to measure systolic and 
diastolic blood pressure according to a standardised protocol. Cuffs 23 cm by 10 or 14 
cm were used, depending on the ann circumference. In children aged over 10 generally 
the largest cuff was used. Blood pressure was measured in the left ann after 15 minutes' 
sitting. Diastolic blood pressure was recorded at the fifth Korotkoff phase. Two blood 
pressure readings were taken and the average was used for analysis. Height and body 
weight were measured with the participant wearing light indoor clothing without shoes. 
Urine samples were analysed for sodium and potassium by flame photometry. Urine was 
Table 3.1.1 Characteristics of the total study group at entry into study. 
Age (yrs) 
Height (em) 
Body weight (kg) 
Systolic blood pressure (nunHg) 
Diastolic blood pressure (mmHg) 
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Mean (SD) 
13.2 (2.7) 
159.3 (16.2) 
48.8 (14.6) 
112.4 (12.9) 
68.4 (8.7) 
Range 
5.9 - 17.0 
115.0 - 193.0 
20.0 - 80.0 
81.0 - 153.0 
44.0 - 97.0 
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collected as six timed overnight samples."·14 The collection began at supper and ended 
with the first urine voided the next morning. Labelled containers were provided, on which 
the subjects noted the times of starting and finishing each collection. From these the mean 
24 hour sodium and potassium intakes were calculated. Electrolyte excretion measured in 
timed overnight urine samples correlates reasonably well with true mean 24 hour 
excretion rates in young subjects. 13,14 The main difference between the two measurements 
is a somewhat higher within person variability in the overnight samples. Both methods 
require multiple samples, and plainly these are more easily collected overnight. 
Data analysis 
Six complete annual records of each subject were used in the analysis. To quantify the 
change in blood pressure during the follow-up period individual slopes of blood pressure 
against time were calculated by using linear regression analysis. The association of 
urinary sodium, potassium, and sodium/potassium ratio, with blood pressure slope was 
analysed by multiple linear regression analysis. To adjust for differences in sex, initial 
age, and change in height and body weight during follow-up, these variables were 
included in the model. When analysing the effect of high sodium intake, adjustments were 
made for potassium intake, and vice versa. Furthermore, to assess the effect of electrolyte 
intake on the change in blood pressure, the study group was divided into subgroups based 
on thirds of the distributions of mean sodium and potassium intake and mean 
sodium/potassium ratio over the follow-up period. In all analyses lower and upper thirds 
were compared. Data are presented as mean changes per year and 95 % confidence 
intervals. Equality of group means was tested for both high and low sodium, potassium, 
and sodium/potassium ratio groups by using analysis of variance. Significance of 
differences was assessed by two tailed tests throughout. To see whether the relation 
between electrolyte intake and change in blood pressure was different in boys and girls or 
in different age groups, the data were analysed by sex and age at the initial survey. The 
median of the initial age distribution was used in stratifying the children for age. In the 
younger group the age range was 5.9-13.7 years and in the older group 13.8-17.0 years. 
Results 
Table 3.1.1 gives the characteristics of the subjects at the start of the study. Changes in 
height, body weight, systolic blood pressure, and diastolic blood pressure during the 
follow-up period are given in table 3.1.2. Table 3.1.3 sholYs the mean values and ranges 
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Table 3.1.2 Yearly rate of change in height, body weight, systolic blood pressure, and diastolic 
blood pressure during follow-up. 
Height (em/year) 
Body weight (kg/year) 
Systolic blood pressure (nuuHg/year) 
Diastolic blood pressure (mmHg/year) 
* Coefficient of linear regression. 
Rate of change*' 
2.61 
2.85 
1.95 
0.58 
95 % confidence interval 
(2.31,2.91) 
(2.60,3.10) 
(1.65, 2.25) 
(0.39,0.77) 
Table 3.1.3 Average excretion of sodium, potassium, and sodium/potassium ratio, and ranges 
according to thirds of distributions of electrolyte excretion in study groups during follow-up. 
Range 
Mean Lower third Upper third 
Sodium excretion (nunol/24h): 
Total study group 135.6 61.5 - 117.7 147.5 - 251.5 
Boys 140.8 61.5 - 127.2 158.2 - 251.5 
Girls 131.1 68.5 - 115.0 139.8 - 215.3 
Younger group 138.4 68.5 - 119.8 147.5 - 251.5 
Older group 132.8 61.5 - 113.5 147.5 - 215.3 
Potassium excretion (mmoIl24h): 
To,!_1 study group 43.7 15.8 - 37.7 47.8 - 77.3 
Boys 47.0 20.2 - 41.5 51.2 - 77.3 
Girls 40.9 15.8 - 35.3 43.5 - 71.0 
Younger group 43.3 15.8 - 37.2 47.3 - 77.3 
Older group 44.1 20.2 - 38.5 47.8 - 75.8 
Sodium/potassium ratio: 
Total study group 3.3 1.1 - 2.8 3.6 - 7.4 
Boys 3.1 1.1 - 2.6 3.4 - 7.4 
Girls 3.3 1.6 - 2.8 3.7 - 5.8 
Younger group 3.3 1.6 - 2.8 3.6 - 5.8 
Older group 3.2 1.1 - 2.6 3.6-7.4 
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of average sodium and potassium excretion, and sodium/potassium ratio, in the lower and 
upper thirds of the study groups during the follow-up. In boys the mean 24 hour sodium 
excretion ranged between 61.5 and 251.5 mmol, which reflects a daily salt intake of 3.6-
14.7 g. In girls the mean 24 hour sodium excretion ranges between 68.5 and 215.3 mmol, 
corresponding to a salt intake of 4.0-12.6 g/day. Potassium intake was higher in boys 
than in girls and therefore the sodium/potassium ratio was higher in girls. During the 
study period age showed no independent association with electrolyte intake. 
Table 3.1.4 shows the association between the yearly rate of change in systolic blood 
pressure and urinary electrolyte excretion. No significant relation between sodium 
excretion and change in systolic blood pressure could be detected. Urinary potassium 
excretion, however, was strongly and inversely associated with systolic blood pressure in 
this cohort (coefficient of linear regression -0.45 nunHg/year/mmol; p=0.OOO4) whereas 
the systolic blood pressure slope was higher when the sodium/potassium ratio was higher 
Table 3.1.4 Association of yearly rate of change in systolic blood pressure with urinary excretion 
of sodium, potassium, and sodium/potassium ratio. * 
Sodium Potassium Sodium/potassium ratio 
Regression coefficientt 0.003 ·0.045 0.356 
(·0.006, 0.012) (·0.069, ·0.020) (0.069, 0.642) 
Mean slope:* 
Lower third 2.04 2.44 1.43 
(1.56,2.52) (1.99, 2.89) (0.97, 1.88) 
Middle third 1.64 1.87 1.91 
(1.19, 2.09) (1.42, 2.32) (1. 46, 2.36) 
Upper third 2.12 1.43 2.24 
(1.65, 2.59) (0.98, 1.88) (1.79, 2.69) 
* Adjusted for differences in sex, initial age and change in height and body weight. Findings for sodium are 
adjusted for potassium excretion, and vice versa; 95% confidence intervals in parentheses. 
t Regression coefficients (mmHg/yr/mmol, or mmHg/yr/unit for sodium/potassium ratio) for the group as a 
whole. 
+ Mean systolic blood pressure slopes (mmHg/yr) in subgroups based on tertiles of the electrolyte excretion 
distributions. 
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(0.356 mmHg/year/unit; p=0.02). The effects of these associations were reflected in the 
levels of annual increase in systolic blood pressure in children in the lower, middle, and 
upper thirds of the distribution of electrolyte excretion (table 3.1.4). 
Figure 3.1.1 shows the differences in rise in systolic blood pressure during follow-up 
between subjects with high and low potassium intakes for the group as a whole and for 
subgroups based on sex and age. Mean yearly change in systolic blood pressure was 1.4 
mmHg in the group with a high potassium intake and 2.4 nunHg in the group with a low 
potassium intake (p=0.007). The difference (1.0 mmHg) amounted to half the average 
yearly change in systolic blood pressure recorded in the group as a whole (table 3.1.2). 
This finding seemed to be most pronounced for boys: 2.1 mmHg/year in those with a 
high intake and 3.1 mmHg/year in those with a low intake (p=0.04). The stratified 
analysis disclosed no clear difference in effect in different age groups. 
Figure 3.1.2 shows the differences in rise in systolic blood pressure between groups 
with high and low urinary sodium/potassium ratios. In children with a high 
sodium/potassium ratio a slope of 2.2 mmHg/year was recorded, compared with 1.4 
mmHg/year in children with a low sodium/potassium ratio (p=0.02). The difference in 
blood pressure slope between the groups with high and low ratios was present in both 
boys and girls. The effect of sodium/potassium ratio on change in systolic blood pressure 
seemed to be stronger in older children. In the group initially aged 13.8-17.0 years the 
difference between the groups with high and low sodium/potassium ratios was 1.0 
mmHg/year (p=0.03). 
Neither sodium, nor potassium, nor the sodium/potassium ratio was significantly 
related to the change in diastolic blood pressure. When the data were reanalysed taking 
initial blood pressure readings into account, results were unaffected. 
Discussion 
The main findings in this longitudinal study were that both potassium intake and the ratio 
of sodium to potassium intake were related to the change in systolic blood pressure in 
childhood. Children with a high dietary intake of potassium had a smaller annual increase 
in systolic blood pressure than children with a low intake. The sodium/potassium ratio 
showed a positive relation with blood pressure. Interestingly, in this age group there was 
no clear effect of sodium intake alone. These fmdings corroborate the report by Lever et 
al., who hypothesised that in the early stages of hypertension blood pressure is raised by 
a process more related to potassium than to sodium." Moreover, fmdings in 
experimental studies suggest that an effect of sodium intake on blood pressure may be 
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Figure 3.1.1 Differences in yearly systolic blood pressure change (mmHglyear) during follow-up 
between children with high and low potassium excretions (mean slope in upper terlile of the 
potassium excretion distribution minus slope in lower tertile). Adjusted for sex, initial age, change 
in height and body weight, and sodium intake; with 95% confidence intervals. 
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Figure 3.1.2 Differences in yearly systolic blood pressure change (nunHglyear) during follow-up 
between children with high and low sodium/potassium excretions (mean slope in upper tertile of 
the sodium/potassium excretion distribution minus slope in lower tertile). Adjusted for sex, initial 
age, and change in height and body weight; with 95 % confidence intervals. 
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present only in older age groupS.16 One trial conducted in newborn infants, however, 
found a small but significant effect of sodium intake on the blood pressure slope during 
the first months of life.17 
The inverse association between potassium intake and the rise in systolic blood pressure 
was similar in the two age groups. By contrast, the relation between the sodium! 
potassium ratio and the blood pressure slope was stronger with age. As this age related 
phenomenon could not be ascribed to either sodium or potassium it was probably related 
to an age dependent interaction between the two. Khaw and Barrett-Connor found an 
increased sensitivity of blood pressure to the dietary sodium/potassium ratio with ageing 
in men. 18 
Some studies have failed to detect a relation between potassium or the sodium! 
potassium ratio and blood pressure in children or adldts.7•19•10 This may be explained in 
several ways. Firstly, in some studies only one urine sample was used to estimate the 
daily sodium and potassium intake. The large intraindividual variability of urinary cation 
excretion, notably sodium, may obscure results. 21 This calls for repeated measurements 
of electrolyte excretion. 14 Sodium and potassium intakes in our study were assessed by 
calculating the mean daily sodium and potassium excretion from six timed overnight urine 
samples. By averaging multiple measurements, the effect of intraindividual day to day 
variability is reduced and sodium and potassium intakes are estimated more precisely. 
Secondly, if the relation between potassium and blood pressure exists only in childhood or 
in the early stages of hypertension, no observable effect might be present in study 
populations that are older.t' Thirdly, in some surveys on potassium the study period was 
quite short. If the effect of potassium becomes evident only after a sufficient time of 
exposure it might be too weak to be detected in these studies. 
There are several ways by which potassium intake might affect the rise in blood 
pressure." Potassium may reduce blood pressure by vasodilatation, thereby causing a 
decrease in total peripheral resistance and an increase in cardiac output. Some studies 
suggest that potassium might lower blood pressure by acting as a diuretic or by altering 
the activity of the renin-angiotensin system. Others give evidence that potassium might 
modify peripheral and central neural regulation of blood pressure. We can draw no 
conclusions from our study about the way that potassium acts. Nor is there a ready 
explanation for a possible mechanism of sodium-potassium interaction. Finally, there 
remains a possibility that potassium intake and the urinary sodium!potassium ratio are 
indicators of another, as yet unknown, determinant of blood pressure change in childhood 
rather than being direct causal factors in blood pressure regulation. 
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In conclusion, this study supports the view that dietary potassium and the dietary 
sodium/potassium ratio may be important in the early pathogenesis of hypertension. 
Possibly a sufficient intake of potassium or a reduction of the dietary sodium/potassium 
ratio in youth may prove to be beneficial in the early prevention of hypertension. 
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Does urinary sodium and potassium excretion in childhood predict 
blood pressure change in early adulthood?' 
Introduction 
There is accumulating evidence that the origins of primary hypertension may be found in 
childhood. '.2.3 Blood pressure in childhood or early adult life rises progressively through 
to middle age, and predicts both the blood pressure level and presence of hypertension in 
later life. 4,5,6,7,8,9,IO,II,12 
Among a population of children first examined in the 1970s, we reported previously a 
significant inverse association between change in systolic blood pressure with age and 
urinary potassium excretion, and a direct association with the urinary sodium/potassium 
ratio, with follow-up to the end of 1985.' To further explore the long-term importance of 
electrolyte excretion in blood pressure development, we present here findings from this 
cohort on change of blood pressure with age over the subsequent six year period (1985-
1991) in relation to earlier values of urinary excretion of sodium, potassium, and 
sodium/potassium ratio obtained between 1978 and 1985. Previous studies have shown a 
fall in blood pressure in girls (but not boys) starting around the age of puberty." The 
analyses were therefore performed separately in subgroups by sex and median age. 
Methods 
Populalion 
Between 1975 and 1978 the total popUlation aged 5 years and over in two districts of 
Zoetermeer, a suburban town in the western part of the Netherlands, was invited to 
participate in a study of risk factors for cardiovascular disease."'" Of 5,670 eligible 
persons aged 5-19 years, 4,649 (82%) were examined. A random sample of 596 
participants was selected for annual follow-up in a study of blood pressure tracking and 
its determinants."'" Participants with established secondary hypertension were excluded. 
We reported previously on 233 of these children, aged up to 17 years at entry, whose 
follow-up included at least six annual examinations in the early phase of the study, i. e., 
up to the end of 1985.' Among tltis subsample, 137 individuals (58%, 75 males and 62 
females) had at least three annual examinations in the late phase of the study, i.e. from 
1986 to 1991, and are included in the present report. The average period of follow-up for 
these individuals was 13 years from entry. The selection of subjects for the present 
analysis is sunm13rised in Figure 3.2.1. 
* III collaboration with ellee D et al .• wndoll School of lIygielle and Tropical Medicille, UK 31 
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Figure 3.2.1 Selection of the study population 
Measurements 
1975-1978 
POPULATION STUDY OF RISK FACTORS OF CARDIOVASCULAR DISEASE 
AMONG 4,649 PARTICIPANTS AGED 5-19 YEARS 
.j. 
596 PARTICIPANTS RANDOMLY SELECTED FOR ANNUAL FOLLOW-UP 
.j. 
1978-1985 
(EARLY PHASB) 
233 PARTICIPANTS WITIr ~6 ANNUAL MEASUREMENTS 
.j. 
1986-1991 
(LATE PHASE) 
137 PARTICIPANTS \VITH ~3 ANNUAL MEASUREMENTS 
.j. .j. 
75 MALES 62 FEMALES 
Blood pressure was measured in the left arm after 15 minutes' sitting by trained 
paramedical workers using a random zero sphygmomanometer according to a standard 
protocol. Cuffs measuring either 23x1O or 23x14 COl were used depending on the arm 
circumference. Two blood pressure readings were taken at each examination and then 
averaged. Height and body weight were measured with the participant wearing light 
indoor clothes without shoes. Overnight urine samples were collected annually. Labelled 
containers were provided on which the participants noted the starting and finishing times 
of each urine collection. Collections began at supper and ended with the fIrst urine voided 
the next morning. Urinary volume was measured, and the urine was analysed for sodium 
and potassium concentrations using flame photometry. Electrolyte excretions were 
standardized to 24 hour values. 
Data analysis 
Urinary excretion of sodium, potassium, and sodium/potassium ratio for each individual 
was taken as the mean of the six ( or more) annual measurements obtained in the early 
phase of the study. 
Change in systolic and diastolic blood pressure with age (mmHg/year) in the late phase 
of the study was estimated for each individual by simple linear regression of blood 
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Table 3.2.1 Characteristics of the participants in the early phase of the study. 
Age (yrs) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Body mass index (kg/m') 
Urinary excretion: 
Sodium (nunoIl24h) 
Potassium (mmol/24h) 
Sodium/potassium ratio 
>[< p<O.OOI, males vs. females. 
Mean (SD) 
Males (n~75) 
14.1 (3.3) 
118.2 (15.9) 
72.2 (9.5) 
19.7 (12.9) 
138.0 (56.7) 
42.1 (20.1) 
4.1 (1.8) 
Females (n ~ 62) 
13.6 (3.1) 
110.5 (10.6)* 
70.6 (8.4) 
19.3 (12.2) 
139.9 (59.4) 
43.5 (21.6) 
3.9 (2.2) 
pressure against age. Changes of height and weight in the late phase were obtained in 
similar fashion. The relationship of the mean urinary variables of the early phase to blood 
pressure change during the late phase was analysed using multiple linear regression, with 
adjustment for sex, mean age and body mass index in the early phase, and change in 
height and weight in the late phase. In addition, when analysing relationships with urinary 
sodium excretion, adjustment was made for urinary potassium excretion and vice versa. 
The number of blood pressure observations in the late phase for each individual was used 
to weight the regression analyses.16 The analyses were performed separately in 
subgroups by sex and age. Age strata were formed by dividing the study group into 
'younger' and 'older' groups according to the median of the age distribution in the early 
phase of the study (14.3 years for males, 13.7 years for females). 
Results 
Characteristics for males and females obtained in the early phase of the study are shown 
in Table 3.2.1. Values were similar in both sexes, except for mean systolic pressure that 
was significantly higher in males (118.2 nunHg, VS. IlO.5 mmHg in females, p<O.OOI). 
Mean urinary excretion during the early phase of the study was around 139 mmol124 hour 
for sodium, around 43 mmo1l24 hour for potassium, and around 4 for sodium/potassium 
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Table 3.2.2 Regression coefficients for average yearly change of systolic and diastolic blood 
pressure (BP), height, and weight in the late phase of the study, divided by median age into 
younger and older age groups (n~ 137). 
b (SE)' 
Males (n~75) Pernales (n~62) 
Younger group Older group Younger group Older group 
Change of: 
Systolic BP (nunHg/yr) 0.22 (0.15) 0.64 (0.16) 0.04 (0.16) -0.15 (0.18) 
Diastolic BP (nunHg/yr) 0,03 (0.15) 0.06 (0.16) 0.22 (0.14) -0.30 (0.14) 
Height (cmJyr) 2.32 (0.15) 1.37 (0.12) 1.86 (0.12) 0.63 (0.16) 
Weight (kg/yr) 1.62 (0.13) 0.84 (0.15) 1.56 (0.13) 0.65 (0.17) 
* Linear regression coefficient (unadjusted) with standard error in parentheses. 
ratio. Yearly changes in systolic and diastolic blood pressure, height, and weight during 
the late phase of the study are shown in Table 3.2.2. The data are presented separately 
for males and females, and are further divided by median age into younger and older age 
groups. For males, there was an increase in blood pressure with age which was more 
marked at older ages. For females, blood pressure increased in the younger group 
« 13.7 years) but decreased at older ages (:e: 13.7 years). 
Table 3.2.3 shows the regression coefficients in males and females for the yearly 
change in systolic and diastolic blood pressures in the late phase of the study in relation to 
urinary sodium, potassium, and sodium/potassium ratio obtained in the early phase. 
Sodium and the sodium/potassium ratio were positively related to change in systolic and 
diastolic blood pressure in males and females. In females, the association of sodium with 
change in diastolic pressure and the association of sodium/potassium ratio with change in 
systolic blood pressure reached statistical significance. For potassium, significant inverse 
associations were observed both with changes in systolic and diastolic blood pressure in 
males and females. 
Discussion 
The study found that among a cohort of children aged 5-17, changes in blood pressure 
with age observed between 1986 and 1991 were positively related to earlier urinary 
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excretion of sodium and sodium/potassium ratio measured between 1978 and 1985. 
Change in systolic and diastolic blood pressure in the late phase was significantly 
inversely associated with earlier urinary potassium excretion. To our knowledge, this is 
the first time that rmdings on electrolyte excretion in relation to future change in blood 
pressure in the same individuals have been reported, potentially with important 
implications for the primary prevention of high blood pressure and frank hypertension in 
later life. 
The participants reported on here were a subsample of a larger cohort. By definition, 
they had high compliance with the annual study measurements, and therefore may not 
have been fully representative of the base population. However, it seems improbable that 
the key findings of a relationship of change of blood pressure with age to earlier 
electrolyte excretion, based on individual data, could have been created by any resultant 
bias. The findings were independent of changes over time in height and weight, or body 
mass index, and again it seems unlikely that they could be explained by unmeasured or 
residual confounding. Blood pressures were based on annual readings using a random-
zero sphygmomanometer according to a standardized protocol. 
Data on change of blood pressure with age were similar to those obtained in other 
cohorts of children, including the fall in blood pressure observed in girls around 
puberty." Estimates of urinary electrolyte excretion were based on overnight urine 
Table 3.2.3 Multiple regression analysis of yearly change in systolic and diastolic blood pressure 
in males and females in the late phase of the study in relation to urinary electrolyte excretions in 
the early phase. 
Sodium Potassium Sodium/potassium ratio 
Systolic BP slope* 
Males 0.Q3 (-0.13, 0.19) -0.31 (-0.09, -0.52)t 0.094 (-0.045, 0.233) 
Females 0.06 (-0.02, 0.14) -0.25 (-0.11, -0.39)t 0.193 (0.043, 0.343)t 
Diastolic BP slope*' 
Males 0.02 (-0.14, 0.18) -0.38 (-0.16, -0.59)t 0.108 (-0.033, 0.249) 
Females 0.54 (0.11, 0.97)t -0.25 (-0.11, -0.39)t 0.086 (-0.033, 0.205) 
* Mean blood pressure slope (mmHg/yr/lO mmol electrolyte excretion, or mmHg/yr/unit sodiUm/potassium 
ratio); adjusted for mean age, body mass index, sodium (potassium model) or potassium (sodium model) in 
early phase, and change of height and weight in late phase; with 95% confidence interval in parentheses. 
t p<0.05. 
35 
Chapter 3.2 
collections, which in young people tend to correlate reasonably well with those obtained 
from 24 hour urine 0Ilections. 17•18 By basing estimates of electrolyte excretion on at 
least six annual urine collections, well-known problems of regression dilution caused by 
the unreliability of a single measure of sodium or potassium excretion were 
minimized. 19,20 
Many studies pointed to a positive association of sodium,21,22,23,24.25,26.27,28 and 
an inverse association of potassium23,29,30,31 with blood pressure, but most of the 
human evidence has been obtained in adults rather than children. While the few trials of 
sodium reduction in children have yielded inconsistent results,"·33.,. a trial among 
newborn babies reported systolic blood pressures at 6 months lower by an average of 2.1 
nunHg among the group randomised to a reduced sodium diet, in comparison with a 
'usual sodium' group.3 
The regression coefficients in the present study indicate that a one standard deviation 
change in urinary excretion of sodium, i.e., around -60 rumol (1.4 g) sodium per day, or 
potassium, i.e., around +20 rumol (0.8 g) potassium per day, could have major impact 
on the future change of blood pressure with age. For example, a lower sodium intake or 
higher potassium intake as indicated above was associated with an average systolic blood 
pressure that was lower by up to 3.6 nunHg and 1.2 nunHg respectively over a lO-year 
period. These figures are of similar magnitude to changes predicted from the 
INTERSALT study, among adults aged 20 to 59 years, of around a 2 nunHg lower 
systolic pressure over a lO-year period for a 60 11111101 lower sodiulII excretion.21 
Differences in average blood pressure of that order are associated with large differences 
in adult risks of coronary heart disease and stroke."·" 
As amply demonstrated by the high lIIean sodium/potassium ratio in this study (in 
excess of four), the diets of children and young people tend to be dominated by processed 
foods high in sodium, and are low in potassium-rich foods such as fruits and vegetables. 
It would seem prudent to move towards a lower sodium/higher potassiulII diet for 
children, as already advocated for adults," for the primary prevention of high blood 
pressure and hypertension in later life. 
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CHAPTER 4 
ELECTROLYTES AND BLOOD PRESSURE 
AT OLD AGE 
THE ROTTERDAM STUDY 

4.1 
Urinary sodium and potassimn excretion and blood pressure 
in older subjects 
Introduction 
A large number of studies have examined the relationship between salt intake of 
populations and the occurrence of hypertension. It has been shown that in primitive 
populations with a low intake of salt, and a concurrently high intake of potassium, 
hypertension is less prevalent than in Western societies. Epidemiologic studies within 
single populations, on the other hand, often fail to demonstrate a relation between 
electrolyte intake and blood pressure. This could be due to the fact that a population 
consists of a heterogeneous group of individuals, whose blood pressures may react quite 
differently to dietary influences. Intervention studies indeed have shown a large variability 
in blood pressure responses upon changes in sodium andlor potassium intake, with some 
people experiencing a blood pressure decrease, others an increase, and others no blood 
pressure change at all.'·2.3 From the viewpoint of prevention, it is worth identifying 
subgroups of people that are expected to respond favourably to specific dietary 
interventions. Age-associated changes in the cardiovascular system and renal function may 
increase the sensitivity of blood pressure to inadequate intake of nutrients in the 
elderly.4.'.6 Studies on the effect of electrolytes on blood pressure at older age, 
however, are still scarce. We investigated whether blood pressure was related to sodium 
and potassium excretion in older participants of the Rotterdam Study. 
Methods 
The Rotterdam Study 
The Rotterdam Study is a population-based study which aims to investigate the occurrence 
and determinants of chronic disabling diseases at older age.' All residents of a suburb of 
Rotterdam over 55 years of age were invited to take part in the study. A total of 7,983 
men and women (78%) agreed to participate. During a home interview, information was 
obtained on current health status, medical history, family history of diseases, education, 
and income by means of a computerised questionnaire. The participants subsequently 
visited the study centre for clinical examination. For the present analysis cross-sectional 
data of the baseline study were used. 
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Measurements 
Two blood pressure readings were taken at the study centre and the average is used in the 
present analysis. Systolic and diastolic blood pressure measurements were performed on 
the right arm using a random-zero sphygmomanometer with a 38 x 14 cm cuff, after the 
participant had been seated for at least five minutes. Data on history of hypertension and 
use of cardiovascular medication were obtained during the home interview by means of a 
questionnaire. A physician checked all packages of medication at the study centre. 
Participants collected an overnight urine specimen before the centre visit. Time of 
collection and urinary volume were recorded. Urinary sodium and potassium were 
analysed by flame photometry. The overnight urinary excretions were standardised to 24 
hour values. 
Population for analysis 
A total of 7,129 subjects (89% of the cohort) visited the study centre. Urinary electrolytes 
were analysed for a random group of 2,564 participants. Time of collection and urinary 
volume were adequately recorded for 1,926 subjects. Blood pressure readings were 
available for 1,876 of those with complete urinary data. Subjects treated with 
antihypertensive drugs (n=590) were excluded from the analyses. Subjects who were not 
treated, but reported a diagnosis of hypertension in the past (n =267), were also excluded 
because they could intentionally have changed their diets. Thirteen subjects were not 
included because of incomplete data on potential confounders. A total of 1,006 
participants was thus left for the present analysis. 
Data analysis 
Linear regression analyses were performed with systolic and diastolic blood pressure as 
the dependent variables. Urinary sodium and potassium were studied separately and 
combined in a multivariate model with adjustment for age, sex, and body mass index. 
Subgroup analyses were performed in men and women. Regression coefficients (b) are 
reported with 95% confidence intervals (95% CI) and two-tailed p-values (P). 
Results 
Characteristics of the study population are shown in table 4.1.1. Thirty-three per cent 
(n=328) of the subjects had a systolic blood pressure above 140 nunHg or a diastolic 
pressure above 90 nunHg. Mean 24 hour sodium excretion was 119 mmol, which 
corresponds to a dietary sodium intake of 2.7 grams (7.0 grams of salt) per day. The 
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Table 4.1.1 Characteristics of the study population (n= 1.006). 
Variable 
Males (%) 
Age (yrs) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (nunHg) 
Heart rate (beats/min) 
Body mass index (kg/m') 
Cigarette smokers (%) 
Alcohol users (%) 
Urinary sodium excretion (mmoIl24h) 
Urinary potassium excretion (mmoI/24h) 
Urinary sodium/potassium ratio 
Mean (SD), 
or percentage 
46 
67.3 (8.4) 
132.2 (20.0) 
70.5 (10.0) 
75.6 (12.0) 
25.8 (3.4) 
26 
66 
119 (61) 
44 (19) 
2.9 (1.3) 
mean 24 hour potassium excretion was 44 mrnol, which corresponds to an intake of 1.7 
grams per day. 
In table 4.1.2 the relations of electrolytes with systolic and diastolic blood pressure are 
presented. Findings are adjusted for age, sex, and body mass index. Urinary sodium 
showed no significant independent relation with blood pressure, but after inclusion of 
potassium in the multivariate model a 100 mrnol increase in sodium was associated with a 
2.2 mrnHg increase in systolic (p=0.06), and a 0.8 mrnHg increase in diastolic blood 
pressure (p=0.14). In men, these associations were 4.0 mmHg/loo mrnol sodium 
(p=O.OI) for systolic blood pressure, and 1.2 mmHg/lOO mrnol sodium (p=0.14) for 
diastolic pressure. In women there was no significant association of sodium with either 
systolic (-0.5 mmHg/loo mrnol sodium, p=0.80) or diastolic pressure (0.2 mmHg/loo 
mrnol sodium, p=0.81). 
Urinary potassium was significantly inversely associated with blood pressure (table 
4.1.2). After adjustment for sodium, a 100 mrnol increase in potassium was associated 
with a 9.4 mmHg decrease in systolic (p=O.OI) and a 4.9 mmHg decrease in diastolic 
blood pressure (p=O.OI). For systolic blood pressure, the association was stronger in men 
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(-11.3 mrnHg/lOO mmol potassium, p=0.02) than in women (-6.3 mruHg/lOO mmol, 
p=0.25). For diastolic blood pressure, the associations were of the same magnitude in 
men (-4.5 mruHg/lOO mmol potassium, p=0.08) and in women (-5.2 mmHg/lOO mmol 
potassium, p=0.07). 
When the analyses were repeated with additional adjustment for heart rate (beats per 
minute), smoking (current, past or never), alcohol use (yes/no), education (7 categories) 
or income (13 categories), the results did not change. 
Discussion 
The present study shows that sodium was not independently related to blood pressure. 
However, when urinary potassium was included in the multivariate regression model a 
positive relation with systolic blood pressure emerged in men. An independent, inverse 
association of urinary potassium with systolic and diastolic blood pressure was observed 
after adjustment for age, sex, and body mass index. The association of potassium with 
blood pressure became stronger after additional adjustment for sodium excretion. 
Table 4.1.2 Association of sodium and potassium excretion with blood pressure (BP) in 1,006 
older men and women. 
Systolic BP (mmHg) Diastolic BP (nunHg) 
b (95% Cl)* P b (95% CI) P 
Separately ill model 
Sodium 0.7 (-1.3,2.7) 0.48 0.0 (-1.0, 1.1) 0.98 
Potassium -5.9 (-12.1,0.3) 0.06 -3.6 (-6.9, -0.4) 0.03 
Sodium/potassium ratio 0.82 (-0.07, 1.71) 0.07 0.32 (-0.14,0.79) 0.18 
Together ill model 
Sodium 2.2 (-0.1,4.5) 0.06 0.8 (-0.4, 2.0) 0.19 
Potassium -9.4 (-16.5, -2.2) 0.01 -4.9 (-8.7, -1.1) 0.01 
* Linear regression coefficient (mmHg per 100 mmol electrolyte excretion, or mmHg per unit 
sodium/potassium ratio) adjusted for age, sex, and body mass index; 95% confidence interval in 
parentheses. 
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Before these rrudings can be accepted, some methodological issues need to be 
considered. Urinary excretions of sodium and potassium are considered to adequately 
reflect the dietary intakes of these electrolytes.' However, excretions are determined by 
recent intakes and a single urine collection cannot be regarded to adequately reflect long-
term dietary exposure. Multiple 24 hour urine samples collected over a period of several 
months would yield a better estimate of habitual intake. In our large population study, 
however, this could not be realised and participants collected a single overnight urine 
sample. Although overnight urinary excretions of sodium and potassium correlate 
reasonably well with 24 hour excretions,'" misclassification of subjects inevitably has 
occurred and the observed relations in the present study are likely to be diluted. 
Furthermore, the choice of our study population may have influenced the strength of the 
observed associations. Subjects who are expected to be most vulnerable to an inadequate 
electrolyte intake, or to an unhealthy lifestyle in general, may have died before reaching 
old age. In addition, subjects who used antihypertensive drugs or reported hypertension 
were excluded from the analyses. 
Though a relationship between sodium and blood pressure has been observed in the 
worldwide INTERSALT study,'· most studies within populations have not been able to 
reproduce this finding. H •12 This could reflect inaccurate assessment of sodium intake or 
blood pressure, or could be due to the fact that the range of salt intake within a single 
population is too restricted to adequately study the effect of high and low intakes on blood 
pressure. An alternative explanation could be that most studies included a large number of 
people who are probably not sensitive to salt intake. It has been suggested that the elderly 
are more sensitive to sodium intake than younger subjects. I .I).l4 In our older study 
population a positive relation between sodium excretion and systolic blood pressure was 
observed, though only in males after adjustment for potassium excretion. The inaccurate 
assessment of sodium intake in our study has probably lead to misclassification and biased 
the regression coefficients towards zero. This may explain why we did not observe a 
relation between sodium excretion and blood pressure in females. 
Studies on potassium intake and blood pressure in older people are scarce and reported 
results are inconsistent. The Scottish Heart Health Study reported a significant 
independent inverse association between 24 hour potassium excretion and blood pressure 
in 7,354 men and women aged 40 to 59. 12 A large Dutch study among middle-aged 
adults, however, could not confirm an association between dietary potassium intake, 
assessed by means of a questionnaire, and blood pressure. I' Recently, a significant dose-
response relationship between change in diastolic blood pressure and 24 hour urinary 
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potassium excretion has been reported in the Trials of Hypertension Prevention (TOHP), 
but the blood pressure effect was small (-1.5 mmHg for the highest vs. the lowest quartile 
of change in urinary potassium).16 In our study, subjects with higher systolic and 
diastolic blood pressure levels had a significantly lower excretion of potassium. The 
regression coefficients suggest that a twofold increase in daily potassium intake could 
theoretically lower systolic blood pressure by 4 mmHg, and diastolic pressure by 2.5 
nmlHg. In men, the observed associations between potassium and blood pressure were 
even stronger. It is possible that blood pressure becomes increasingly sensitive to an 
inadequate intake of potassium at older age. The INTERSALT study reported stronger 
associations between potassium excretion and blood pressure with increasing age. I7 
The dietary sodium/potassium ratio has been related to blood pressure levels, and could 
be a better predictor of blood pressure than either of the nutrients alone.13 A recent trial 
among older untreated hypertensive subjects demonstrated a substantial reduction in blood 
pressure when sodium intake was reduced and potassium intake increased by means of a 
mineral salt. 18 In the present analysis, however, the sodium/potassium ratio was only 
weakly positively related to systolic and diastolic blood pressure. This may in part be 
explained by inaccurate assessment of both sodium and potassium intake by the single 
overnight urine collection. 
In conclusion, our findings suggest that a high sodium intake may adversely affect 
blood pressure, especially in older men. A high intake of potassium, on the other hand, 
could have a favourable effect on blood pressure level in older men and women. The 
effect of electrolyte intake on blood pressure and the potential for prevention and 
intervention in the elderly warrants further investigation in controlled intervention studies. 
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4.2 
Dietary electrolyte intake and blood pressure in older subjects 
Introduction 
Dietary electrolyte intake could be an important, modifiable determinant of blood 
pressure. 1•2 Therapeutic dietary modifications are particularly relevant at older age as 
more adverse effects of antihypertensive drugs are experienced and compliance to drug 
therapy often becomes poorer. '.. Furthermore, age-associated changes in the 
cardiovascular system could increase the sensitivity of blood pressure to inadequate intake 
of nutrients.'·'·' Studies on the influence of electrolytes on blood pressure at older age, 
however, are still scarce. We investigated whether blood pressure was related to the 
intake of potassium, magnesium, and calcium in older participants of the Rotterdam 
Study. 
Methods 
The ROllerdam Study 
The Rotterdam Study is a population-based study which aims to investigate the occurrence 
and determinants of chronic disabling diseases at older age. 8 All residents of a suburb of 
Rotterdam over 55 years of age were invited to take part in the study. A total of 7,983 
men and women (78%) agreed to participate. During a home interview, infOlmation was 
obtained on current health status, medical history, family history of diseases, education, 
and income by means of a computerised questionnaire. The participants subsequently 
visited the study centre for clinical examination and an interview with a dietician. For the 
present analysis cross-sectional data of the baseline survey were used. 
Blood presslIre measuremellls 
Two blood pressure readings were taken at the study centre and the average is used in the 
present analysis. Systolic and diastolic blood pressure measurements were performed on 
the right arm using a random-zero sphygmomanometer with a 38 x 14 cm cuff, after the 
participant had been seated for at least five minutes. Data on history of hypertension and 
use of cardiovascular medication were obtained during the home interview by means of a 
questionnaire. A physician checked all packages of medication at the study centre. 
Diefmy assessment 
Before visiting the study centre the participants received a checklist on which they 
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indicated all foods and drinks that they regularly consumed (i.e. once a month or more) 
during the preceding year. The completed checklist was subsequently used as the basis for 
a detailed interview by a trained dietician at the study centre who was not informed about 
the purpose of the present study and blinded with regard to the blood pressure levels of 
the participants. Seasonal variations in the diet were taken into account. The dietician 
registered quantities and frequencies of consumption on a semiquantitative food frequency 
questionnaire. The questionnaire comprised 170 food items in 13 food groups and was a 
modified version of a self-administered questionnaire that had been used and validated 
previously in a large prospective study in the Netherlands.' During the course of the 
study a computerised version of the questionnaire was introduced, which contained 
multiple checks on the data. The dietician used this computerised questionnaire in 59% of 
the interviews. Intakes of potassium, magnesium, calcium, alcohol, and total energy were 
calculated from the food data with the use of Dutch food composition tables.1O Sodium 
intake could not adequately be assessed by the food frequency questionnaire. 
Population for analysis 
A total of 7,129 subjects (89% of the total cohort) visited the research centre. No dietary 
information was obtained from participants of the Rotterdam Study pilot phase (n=271) 
and from nursing homes residents (n=635). Participants that scored low on 
neuropsychological testing (n= 122) were not interviewed because they were considered 
unable to adequately recall dietary intakes. For logistic reasons, no interview was carried 
out in a random group of 455 subjects. Diet was thus assessed in 5,646 participants. Two 
hundred and twelve subjects were excluded because they did not fully cooperate during 
the interview and the dietician considered their reported diets unreliable. Blood pressure 
readings were available for 5,153 of the remaining participants. Subjects treated with 
antihypertensive drugs (n=I,587) were excluded from the analyses. In addition, subjects 
with a salt-restricted diet (n=49), subjects who reported regular use of mineral 
supplements (n=257), and subjects with incomplete data on potential confounders (n=21) 
were excluded. A total of 3,239 participants was left for the present analysis. 
Data analysis 
Dietary potassium, magnesium and calcium were adjusted for energy intake by regressing 
the electrolyte intakes on total energy and adding the residuals to the mean intakes, as 
described by Willett et al. II Linear regression analyses were performed with systolic and 
diastolic blood pressure as the dependent variables. Energy-adjusted electrolyte intakes 
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were studied separately and in combination in the multivariate model with adjustment for 
age, sex, body mass index, and alcohol intake. The analyses were repeated in predefined 
subgroups, i.e. men and women, younger and older subjects (below or above the median 
of the age distribution), and normotensive and hypertensive subjects (blood pressure 
below or above 140/90 mmHg). Regression coefficients (b) are reported with standard 
errors (SE) and two-tailed p-values (P). P-values below the a-level of 0.05 were 
considered statistically significant. 
Results 
Characteristics of the study population are shown in table 4.2.1. Forty-two percent 
(n=I,360) of the subjects had a systolic blood pressure above 140 mmHg or a diastolic 
pressure above 90 mmHg, and 21 % (n=670) reported a diagnosis of hypertension in the 
Table 4.2.1 Characteristics of the study population (0=3,239). 
Variable 
Males (%) 
Age (yrs) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Body mass index (kg/m') 
Cigarette smokers (%) 
Alcohol users (%) 
Dietary intake: 
Total energy (kcal/day) 
Alcohol (g/day)' 
Potassium (mg/day) 
Magnesium (mg/day) 
Calcium (mg/day) 
* Alcohol intake among alcohol users. 
Mean (SD), 
or percentage 
43 
66.8 (7.6) 
136.3 (21.4) 
73.0 (11.0) 
25.5 (3.4) 
24 
81 
2022 (512) 
13.7 (16.7) 
3700 (824) 
311 (75) 
1127 (398) 
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past. Age, body mass index, and alcohol intake were significantly associated both with 
systolic and diastolic blood pressure. Sex was significantly associated with diastolic blood 
pressure only (table 4.2.2). Total energy intake, smoking (number of cigarettes per day), 
education (7 categories), and income (13 categories) were not significantly associated with 
blood pressure (data not shown). 
In table 4.2.3 the relations of energy-adjusted electrolyte intakes with systolic and 
diastolic blood pressure are presented. Findings were adjusted for age, sex, body mass 
index, and alcohol intake. Potassium intake was inversely associated with systolic 
(regression coefficient -0.9 nuuHg/gram potassium, p=O.lI) and diastolic blood pressure 
(-0.8 nuuHg/gram potassium, p=O.OI). The relation between potassium and diastolic 
blood pressure was more pronounced in men (-1.2 nuuHg/gram potassium, p=O.OI) than 
in women (-0.5 nuuHg/gram potassium, p=0.25). For systolic blood pressure, the 
association was similar in men and women. Regression coefficients for potassium did not 
differ significantly between younger and older subjects, or between hypertensives and 
nonnotensives. After adjustment for magnesium and calcium, the associations of 
potassium with blood pressure for the group as a whole were weaker (-0.75 and -0.39 
nuuHg/gram potassium for systolic and diastolic pressure respectively) and no longer 
statistically significant. 
An increase of 100 mg in magnesium intake was associated with a 1.2 nuuHg decrease 
in systolic (p=0.07) and a 1.1 nuuHg decrease in diastolic blood pressure (p<O.OI). The 
association of magnesium with systolic blood pressure was more pronounced in men (-1.8 
nuuHg/100 mg magnesium, p=0.06) than in women (-0.9 nuuHg/100 mg magnesium, 
p=0.36). This was also the case for diastolic blood pressure (-1.4 mmHg/100 mg 
magnesium (p<O.OI) in men, compared to -0.8 nuuHg/100 mg magnesium (p=O.13) in 
women). The associations of magnesium with blood pressure were similar in younger and 
older subjects, and in hypertensives and normotensives. After sinlUltaneous inclusion of 
potassium and calcium intake in the regression model, the association of magnesium with 
systolic blood pressure for the group as a whole became stronger (-1.8 mmHg/100 mg 
magnesium, p=0.09), whereas the results for diastolic pressure remained unchanged. 
Dietary calcium was not significantly independently associated with blood pressure, 
except for a subgroup of 1,360 hypertensive subjects in which a significant inverse 
association of calcium with diastolic blood pressure was observed (-2.2 nunHg/gram 
calcium, p=O.OI). In other subgroups, associations of calcium with blood pressure did 
not differ from the results obtained in the group as a whole. After simultaneous inclusion 
of potassium and magnesium in the regression model, a significant positive association of 
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calcium intake with systolic blood pressure emerged (3.4 nunHg/gram calcium, p=O.Ol). 
When the analyses were repeated with additional adjustment for smoking, education or 
income the results did not change. Similar results were also obtained when subjects who 
reported a diagnosis of hypertension in the past, but were not currently treated with 
antihypertensive drugs, were excluded from the analyses. 
Discussion 
Within the older population of the Rotterdam Study, dietary potassium and magnesium 
intake were inversely and independently related to systolic and diastolic blood pressure 
after adjuswent for age, sex, body mass index, and alcohol intake. Calcium intake 
showed no independent relation with blood pressure, except within hypertensive subjects 
where a significant inverse association with diastolic blood pressure was observed. When 
all electrolytes were considered together in the regression model, potassium and 
magnesium retained their inverse associations with systolic and diastolic blood pressure. 
For calcium, however, a significant positive association with systolic blood pressure 
emerged. 
Some limitations of the study need to be discussed. First, we could not study the effect 
of sodium, because salt use during cooking and dining could not adequately be assessed 
by the questionnaire that we used in our study. A fruit- and vegetable-rich diet, which is 
the main provider of potassium and magnesium, is generally a healthy diet that contains 
Table 4.2.2 Association of age, sex, body mass index, and alcohol intake with blood pressure 
(BP) in 3,239 older men and women. 
Systolic BP (nunHg) Diastolic BP (nm1Hg) 
b (SE)* p b (SE) p 
Intercept 59.3 67.3 
Age (yrs) 0.77 (0.05) <0.0001 -0.10 (0.03) <o.{)()()} 
Sex (O=male, I = female) -0.56 (0.76) 0.46 -1.50 (0.41) <0.{)()()1 
Body mass index (kg/m') 0.98 (0.10) <o.ooo} 0.51 (0.06) <0.{)()()1 
Alcohol intake (g/day) 0.07 (0.02) 0.0} 0.03 (0.01) 0.01 
* Linear regression coefficient with standard error in parentheses (all variables in model). 
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Table 4.2.3 Association of energy-adjusted electrolyte intakes with blood pressure in 3.239 older 
men and women. 
Systolic BP (nunHg) Diastolic BP (nunHg) 
b (SE)* p b (SE) p 
Separately ill model 
Potassium (g/day) -0.94 (0.59) 0.11 -0.84 (0.31) 0.01 
Magnesium (mg/day) -0.012 (0.007) 0.07 -0.011 (0.004) <0.01 
Calcium (g/day) 1.30 (1.03) 0.21 -0.33 (0.55) 0.55 
Combined ill model 
Potassium (g/day) -0.75 (0.91) 0.41 -0.39 (0.66) 0.42 
Magnesium (mg/day) -0.018 (0.011) 0.09 -0.011 (0.006) 0.06 
Calcium (g/day) 3.43 (1.24) 0.01 0.91 (0.66) 0.17 
* Linear regression coefficient adjusted for age, sex, body mass index, and alcohol intake with standard 
error in parentheses. 
fewer fatty and salty foods. The observed inverse associations of potassium and 
magnesium with blood pressure could therefore partially result from a low intake of 
sodium. Second, it should be noted that the choice of our study population may have 
influenced the strength of the observed associations. Subjects who are expected to be most 
vulnerable to an inadequate electrolyte intake, or to an unhealthy lifestyle in general, may 
have died before reaching old age or have been using antihypertensive drugs. These 
people were proportionately less well represented in our study. Finally, when nutrients 
are studied in relation to disease it is difficult to rule out completely confounding 
influences. Dietary patterns are closely related to other factors that may also influence 
blood pressure, such as age, alcohol consumption, body weight, education, and physical 
activity. We considered most of these variables in our analyses, but could not adjust for 
physical activity. This may have given rise to residual confounding, because a healthy 
lifestyle with regular physical activity is associated with a higher intake of potassium and 
magnesium through fruits and vegetables, and lower blood pressure levels. However, total 
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energy intake, which is correlated with physical activity, 12 was not associated with blood 
pressure in our older population. 
Studies on potassium and blood pressure in older people are scarce. The potassium 
content of the diet has been related to blood pressure in a number of observational studies 
among middle-aged men and women, but findings are inconsistent.I'.1< Cappuccio and 
MacGregor summarized 19 published trials of the effect of potassium supplementation on 
blood pressure. Blood pressure reductions of 5.9 nunHg systolic and 3.4 mmHg diastolic 
were observed with an average, substantial increase in potassium intake of 86 mmol (3.4 
grams) per day. IS Recently, a significant dose-response relationship between change in 
diastolic blood pressure and 24-hour urinary potassium excretion has been reported in the 
Trials of Hypertension Prevention (TOHP), but the blood pressure effect was small (-1.5 
nunHg for the highest vs. the lowest quartile of change in urinary potassium).16 In a trial 
among hypertensive elderly, potassium supplementation resulted in a significant blood 
pressure reduction,17 which is in agreement with the results of our study. We found that 
lower potassium intakes were observed in subjects with higher blood pressure levels. Tltis 
suggests that blood pressure levels in the elderly adversely respond to an inadequate 
intake of potassium. 
We observed an inverse relationship of magnesium with systolic and diastolic blood 
pressure. Some other large population studies have previously suggested a role for 
magnesium in determining blood pressure level.I'.I' A trial among middle-aged and 
older Dutch women showed a 3.4 nunHg decrease in diastolic blood pressure when daily 
magnesium intake was doubled." The TOHP, on the contrary, could not achieve a blood 
pressure reduction after 3 or 6 months of intervention with magnesium supplements in 
ntiddle-aged adults.21 Possibly, the effect of magnesium on blood pressure becomes 
apparent only at older age, which could explain the inverse association between 
magnesium and blood pressure in our study. An alternative explanation for our findings 
could be the strong association of magnesium intake with intake of fibre, an agent that 
may also lower blood pressure. 
Many observational studies have reported an inverse association between calcium intake 
and blood pressure,'·22 though negative results have also been reported." We observed 
an independent relation of calcium intake only with diastolic blood pressure in 
hypertensive subjects. Possibly, the sensitivity of calcium increases with blood pressure 
level. Drug-treated hypertensive subjects were removed from our analysis, wltich may 
explain why no relation was observed in the group as a whole. Furthermore, the majority 
of our subjects had an adequate intake of calcium, whereas other studies that showed an 
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inverse association with blood pressure reported lower calcium intakes. An unexpected 
positive relation of calcium intake with systolic blood pressure emerged after adjustment 
for potassium and magnesium intake. Because the association was not consistent and 
disagrees with findings in previous studies, this probably resulted from multicollinearity. 
This problem occurs when the variation in one variable is substantially reduced because of 
the inclusion of one or more other variables. Possibly, the relation estimated from the 
residual variation after removing the effect of potassium and magnesium is not attributable 
to calcium itself, but to other factors that are associated with calcium intake and not with 
potassium and magnesium intake. Intake of saturated fat, for example, is correlated with 
calcium intake through consumption of dairy products and may have given rise to the 
unexpected, positive relation with blood pressure. Nevertheless, we cannot rule out the 
possibility that the influence of calcium on blood pressure becomes different at advanced 
age as a result of age-related changes in biological mechanisms. A positive association 
between calcium and blood pressure in elderly Chinese subjects has previously been 
reported by Woo el al.24 
The complexity of the human diet makes it difficult to separate the effect of any 
specific nutrient from possible effects of other nutrients. The intake of potassium is highly 
correlated with the intake of magnesium as both minerals are often ingested together 
through the same vegetables and fruits. The problem of multicollinearity cannot 
adequately be solved by statistical methods. The simultaneous inclusion of strongly 
correlated variables in a multivariate regression model may give rise to unanticipated, 
spurious results. In our study, this was probably the case when dietary potassium and 
magnesium were included in the multivariate model together with dietary calcium. 
Although our data are not incompatible with independent effects of potassium and 
magnesium intake, inference from observational studies can probably best focus of 
mixtures of nutrients rather than on individual factors. Our findings suggest that an 
increase in the intake of foods rich in potassium and magnesium could lower blood 
pressure at older age. 
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Reduction in blood pressure with a low sodium, high potassium, high 
magnesium salt in older subjects with mild to moderate hypertension 
Introduction 
Results from many studies suggest a role for minerals in blood pressure regulation. 
Sodium may increase blood pressure', whereas the reverse bas been reported for 
potassium and magnesium.2•3 Several studies have shown a stronger relation of the 
sodium/potassium ratio with blood pressure than sodium or potassium alone."'" Hence, 
dietary measures to reduce blood pressure might be more effective when the intake of 
several minerals is changed simultaneously. Older subjects with a high blood pressure 
may benefit most from salt restriction, as the strength of association between sodium and 
blood pressure increases with age and blood pressure in cross-sectional studies.'" Results 
of intervention studies support this hypothesis, though most trials have focused on young 
and middle-aged subjects.8•9 Intervention studies in elderly people addressing multiple 
modest changes in mineral intake are needed to assess the potential of tItis intervention for 
blood pressure lowering at advanced age. 
We conducted a randomised, double blind, placebo controlled trial of the effect of a 
reduced sodium intake and increased potassium and magnesium intake on blood pressure 
by using a mineral salt (sodium:potassium:magnesium (mmol) 8:6: 1)*, in older subjects 
with mild to moderate hypertension. 
Methods 
Subjects 
Subjects were recruited from the population based cohort of the Rotterdam Study, which 
consists of non-hospitalised older inhabitants of a suburb of Rotterdam. Details of the 
study have been reported.'O.ll All subjects had their blood pressure measured between 
1990 and 1992. Men and women, aged 55 to 75, with a blood pressure above 140 mmHg 
systolic or 85 mmHg diastolic without antihypertensive treatment (n=419), were invited 
by letter and telephone for remeasurement of blood pressure. To be eligible for the trial, 
subjects' systolic blood pressure had to be between 140 and 200 mmHg or diastolic blood 
pressure between 85 and 110 mmHg at two measurements one week apart. In addition, 
systolic blood pressure had to be not below 130 mmHg and diastolic pressure not below 
70mmHg. 
* SagaSal/~ 
Dutch product name 'Jozo Vilaal', distributed by Akzo Nobel Salt Europe 59 
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Table 4.3.1 Baseline characteristics of subjects in the control group and mineral salt group. 
Controls Mineral salt group 
(n~51) (n~49) 
Male/female 25/26 26/23 
Age (years) 67.1 (4.5) 65.7 (4.6) 
Blood pressure (mmHg): 
Systolic 157.5 (12.8) 158.0 (15.0) 
Diastolic 90.8 (8.9) 89.8 (9.6) 
Pulse rate (beats/min) 80.6 (12.6) 77.7 (12.6) 
Height (em) 167.0 (9.1) 169.2 (9.4) 
Body weight (kg) 76.0 (11.3) 77.5 (10.1) 
Body mass index (kg/m') 27.2 (3.2) 27.1 (3.4) 
No (%) of cigarette smokers 12 (23.5) 9 (18.4) 
Serum: 
Sodium (nunolll) 137.1 (2.4) 137.0 (3.1) 
Potassium (nunol/I) 4.2 (0.4) 4.3 (0.3) 
Magnesium (nunol/I) 0.86 (0.06) 0.86 (0.06) 
Calcium (mmol/l) 2.4 (0.1) 2.4 (0.1) 
Ionised calcium (mmol/I) 1.24 (0.04) 1.24 (0.04) 
Urine: 
Sodium (mmol/day) 138 (50) 139 (52) 
Potassium (mmol/day) 81 (25) 86 (22) 
Sodium/potassium ratio l.8 (0.6) 1.6 (0.4) 
Magnesium (mmol/day) 5.2 (1.7) 5.4 (1.9) 
Calcium (mmol/day) 4.8 (2.2) 4.7 (1.9) 
Creatinine (mmol/day) 10.2 (2.8) 10.0 (2.7) 
Values are means with standard deviations in parentheses. except where stated otherwise. 
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Subjects with a history of myocardial infarction, angina pectoris, diabetes mellitus, or 
impaired renal function (serum creatinine > 200 Jlmolll) or eating a salt restricted diet on 
medical advice were excluded. Thirty subjects could not be contacted. A total of 125 
subjects were excluded after being contacted by telephone because they showed no 
interest (n=56) or because they met one of the exclusion criteria (n=69). Of the 264 
subjects who eventually had their blood pressure remeasured (63 % of those initially 
invited), 17 did not fulfil blood pressure criteria, 40 had started antillypertensive 
treatment, 55 met other exclusion criteria, and 52 refused the trial. This left 100 subjects 
who were randomised. 
Pr%col 
Randomisation was carried out within eight strata defined by sex and baseline blood 
pressure by using a computerised randomisation table. During 24 weeks, the intervention 
group received a mineral salt (sodium:potassium:magnesium (mmol) 8:6: 1) for use in 
cooking and at the table, and foods prepared with the mineral salt. The control group 
received common salt (sodium chloride) and foods prepared with common salt. The 
mineral salt is extracted from natural sources in Iceland and consists of 41 % sodium 
chloride, 41 % potassium chloride, 17% magnesium salts, partly as potassium-magnesium 
double salts (carnallite and kainite), and 1 % trace minerals. 12 
Trial foods included bread, cheese, luncheon meats, canned and instant soups, and 
smoked sausage. Together these foods provide around 57 % of the salt intake of the Dutch 
elderly population." The sodium/potassium ratio (mmollmmol) ranged from 1.3 (cheese) 
to 1.8 (canned soups) in mineral salt foods and from 6.7 (smoked sausage) to 22.7 
(instant soups) in control foods. Salt and foods for both groups looked identical and were 
provided free of charge by means of a double blind coding system based on the 
randomisation numbers. Participants were asked to avoid changes in dietary habits and 
lifestyle, to adhere as much as possible to the trial salt and foods, and to register 
deviations from the protocol in a diary. For each subjects we recorded the amount of 
foods provided. We contacted subjects monthly to check and encourage compliance. 
The protocol was approved by the medical ethics committee of Erasmus University. All 
participants gave written informed consent. During the study, participants were not told 
the results of blood pressure measurements. 
Measurements 
Blood pressure, pulse rate, and body weight were assessed at baseline and after 8, 16 and 
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24 weeks of intervention. To obtain stable estimates blood pressure and pulse rate were 
measured at two visits with a week's interval (baseline, week 8 and week 16) or at tbree 
visits with weekly intervals (week 24) and the average taken as the estimate. Baseline 
blood pressure was the average of the last blood pressure screening and baseline 
measurements. Blood pressure was measured on the right arm by two investigators, using 
an automatic device (Dinamap model 8100; Critikon Inc, Florida) and a 51 em by 15 em 
cuff while the participant was seated. After at least five minutes' rest four measurements 
were taken, of which the last tbree were averaged. Body weight and height were 
measured without heavy clothing and shoes. Body mass index was computed as weight 
(kg) divided by height (m) squared. Subjects collected two successive 24 hour urine 
samples at baseline and at 8, 16 and 24 weeks. 
Every eight weeks the subjects answered a questionnaire on health complaints, 
smoking, alcohol intake, physical activity, and drug use during the preceding period. At 
eight weeks subjects evaluated the appearance, saltiness, and palatability of the trial foods 
by filling in a questionnaire with five point rating scales. During intervention a dietician 
visited the subjects at home and used a sensitive balance to weigh the amount of trial salt 
added during cooking (pM 300 balance; Mettler-Toledo AG, Switzerland). Information on 
salt use was obtained by means of a questionnaire. 
We sampled blood at baseline and at 24 weeks. Serum ionised calcium concentration 
was analysed with an ion selective electrode (lCA2 Ionized Calcium Analyzer, 
Radiometer, Copenhagen) and reported values are pH adjusted. Analyses of other 
electrolytes in blood and urine were performed by standard methods. Four to nine months 
after the study all subjects were invited again for blood pressure measurement. On this 
occasion we asked which salt the subject thought he or she had received during the study. 
Data analysis 
Changes in blood pressure and electrolyte excretion from baseline were compared 
between the control group and the mineral salt group. In addition, preplanned subgroup 
analyses were performed according to sex and age. The hypothesis of no difference 
between the groups was tested by a two sided t test. Results are expressed as means and 
95 % confidence intervals of the differences between groups. Adjustment of change in 
blood pressure for potential confounders was performed by analysis of covariance. Data 
analysis was carried out on an intention to treat basis. The study sample was large enough 
to detect a difference in blood pressure of 5 mmHg systolic and 4 mmHg diastolic with a 
power of 0.90 and a two sided p value of 0.05. 
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Table 4.3.2 Changes in blood pressure (BP) from baseline (51 controls, 49 subjeclS in mineral salt group), adjusted for cbange in body weigbt. 
Week 0 Week 8 Week 16t Week24~ Intervention§ 
Systolic BP (mrriHg); 
Controls 157.6 (2.0) 161.0 (2.1) 160.0 (2.2) 156.0 (1.9) 158.5 (I.S) 
Mineral salt group 157.9 (2.0) 151.S (2.1) 152.6 (2.2) 150.9 (1.9) 151.7 (I.S) 
Difference -9.7 (-13.6, -5.7) -S.7 (-13.0, 4.5) -7.7 (-12.3, -3.1) -8.7 (-12.2, -5.2) 
(95% confidence interval)* p<O.OOl p<O.OOl p=O.OOl p<O.OC)1 
Diastolic BP (mrriHg); 
Controls 91.0 (1.3) 92.7 (1.4) 92.3 (1.4) 90.9 (1.2) 92.1 (1.2) 
Mineral salt group 89.7 (1.3) 87.0 (1.4) 86.7 (1.4) 86.S (1.2) 86.9 (1.2) 
Difference 4.2 (-7.0, -1.4) 4.0 (-7.1, -0.9) ·2.8 (-5.S, 0.2) -3.6 (-6.0, -1.1) 
(95 % confidence interval) p~O.OO4 p=O.Ol p~O.06 p=o.oos 
Values are means with standard error in parentheses. 
* Difference in change from baseline between study groups. t Values for week 16 missing for one control and one subject in the mineral salt group. 
§ Mean of measurements at weeks 8, 16, and 24. :t: Values for week 24 missing for twO controls and one subject in the mineral salt group. 
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Results 
Complete follow up was achieved by 97 of the 100 randomised subjects. Two of the 
controls withdrew after eight and 16 weeks because of admission to hospital for 
complaints not related to intervention. One person withdrew in the mineral salt group 
after six weeks because of dislike of the foods. 
Randomisation established comparable study groups (table 4.3.1). Figure 4.3.1 presents 
blood pressure at baseline and during intervention. A difference in blood pressure change 
between the groups was present at eight weeks and persisted throughout. Systolic blood 
pressure (mean of measurements at weeks 8, 16 and 24) feU by 7.6 mmHg (95% 
confidence interval 4.0 to 11.2; p<O.OOI) and diastolic blood pressure by 3.3 mmflg 
(0.8 to 5.8; p=0.OO9) in the mineral salt group compared with the controls. After 
adjustment for change in. body weight, values were 8.7 mmHg en 3.6 mmHg (table 
4.3.2). The decrease in blood pressure was of the same magnitude in men and women 
and not modified by age (data not shown). 
Table 4.3.3 shows the changes in body weight and electrolyte excretion from baseline. 
The 24 hour sodium excretion decreased on average by 28% (that is, by 38.4 mmol; 95% 
confidence interval 24.0 to 52.8); p<O.OOI) and potassium excretion increased by 22% 
(17.5 nunol (7.9 to 27.0); p<O.OOI) in the mineral salt group compared with the controls 
(fig 4.3.2). Urinary calcium and magnesium excretion did not change. Results were 
similar after adjustment for urinary creatinine excretion. Urinary volumes in both groups 
remained stable during intervention (data not shown). Change in body weight was on 
average 0.50 kg (95% confidence interval -0.03 to 1.03; p=0.06) more in the mineral 
salt group than in the controls. Serum electrolyte concentrations (table 4.3.4) were 
unchanged in both groups. Change in pulse rate during intervention was not significantly 
different between the groups (data not shown). 
Appearance, saltiness, and palatability of the trial foods were rated equally by the two 
groups except for the bread and table salt, which were considered less salty by 
significantly more people in the mineral salt group than in the control group. None of the 
participants reported the flavour of the trial salt and foods as unpleasant. Seven per cent 
of the controls (3/44) reported a higher discretionary salt use during the trial as compared 
with 40% (16/40) of the mineral salt group. Salt use as assessed by weighing was similar 
in both groups - namely, 4.9 g (SD 4.8; range nil to 24.1 g) in the control group and 5.2 
g (4.9; nil to 26.2 g) in ihe mineral salt group (p=0.74). 
Reports of side effects and lifestyle changes during intervention were minimal and 
equally distributed among the study groups. The records of salt and foods provided and 
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the diaries on compliance indicated good adherence to the protocol in both groups. 
Twenty five weeks (SD 4; range 16-37) after the study all 51 controls and 46 subjects 
from the mineral salt group (94 %) visited the study centre. Differences in blood pressure 
change from baseline between the groups were 0.8 rnmHg (95% confidence interval -4.5 
to 6.0; p=0.77) systolic and -1.0 mmHg (-4.5 to 2.5; p=0.57) diastolic in untreated 
subjects. Sixteen of the controls (31 %) compared with 33 (72%) subjects from the 
mineral salt group believed they had received mineral salt when asked after the trial. 
Table 4.3.3 Body weight and electrolyte excretion at baseline and during intervention. t 
Week 0 Week 8 Week 16 Week 24 
Body weigllt (kg): 
Controls 76.0 (1.6) 76. I (1.6) 76.7 (1.6) 76.0 (1.7) 
Mineral salt group 77.5 (1.4) 78.4 (1.4) 78.9 (1.5) 78.9 (1.4) 
SodiulII (1111110112411): 
Controls 138 (7) 147 (7) 147 (7) 148 (7) 
Mineral salt group 139 (8) I I3 (5) 107 (5) II6 (4) 
Potassium (mmoIl24h): 
Controls 81 (4) 77 (3) 77 (4) 75 (3) 
Mineral salt group 86 (3) 102 (4) 101 (5) 97 (4) 
Sod;,ulI/potassium ratio: 
Controls 1.8 (0. I) 2.0 (0.1) 1.9 (0.1) 2.1 (0.1) 
Mineral salt group 1.6 (0.1) 1.I (0. I) 1.I (0.1) 1.3 (0.1) 
MagnesiulII (IIImoIl2411): 
Controls 5.2 (0.2) 5.8 (0.2) 5.5 (0.3) 5.4 (0.3) 
Mineral salt group 5.4 (0.3) 6.1 (0.3) 5.8 (0.3) 5.7 (0.3) 
CalciulII (1111110112411): 
Controls 4.8 (0.3) 4.8 (0.3) 4.6 (0.3) 4:9 (0.2) 
Mineral salt group 4.7 (0.3) 4.4 (0.3) 4. I (0.2) 4.3 (0.3) 
Values are means with standard error in parentheses. 
t On each occasion values for body weight and electrolyte excretion were obtained for at least 47 controls 
and 45 subjects in the mineral salt group. 
65 
Chapter 4.3 
Within the study groups, observed blood pressure changes during intervention did not 
differ between those who thought they had been given mineral salt and those who thought 
they had been given common salt or did not know. 
Discussion 
We observed a decrease in systolic and diastolic blood pressure in older hypertensive 
subjects when sodium intake was lowered and potassium and magnesium intake was 
increased by means of a mineral salt. However, before these results can be accepted some 
aspects of the trial need to be discussed. 
We provided salt and foods which were palatable and eaten regularly by the 
participants in both groups. This was reflected in a persistent difference in sodium and 
potassium excretion between the study groups. From Dutch food tables" the daily 
magnesium intake was estimated to be 7 nunol higher in our mineral salt group than in 
the controls though this was not reflected in the urinary excretion values. The intervention 
effect on blood pressure in the mineral salt group seemed to be fully achieved after eight 
weeks and persisted throughout the study. After the trial the participants switched back to 
sodium salt and foods were no longer provided. The difference in blood pressure was no 
longer detectable 25 weeks after the study. No data on urinary electrolyte values were 
obtained at that time. 
Culler ef al. reviewed 23 randomised trials and concluded that a 50 to 100 mmol 
reduction in sodium excretion per 24 hours was associated with a blood pressure fall of 
4.9 nunHg systolic and 2.6 nunHg diastolic in hypertensive subjects.' A mean reduction 
of 38 mmoll24h in sodium excretion was achieved in our study. In a meta-analysis of 19 
trials Cappuccio and MacGregor reported a fall in supine blood pressure of 5.9 nunHg 
systolic and 3.4 nunHg diastolic with a threefold to fourfold higher increase in potassium 
excretion than in this study. IS Cross-sectional data from the INTERSALT study 
predicted smaller decreases of 1.9 and 1.2 nunHg respectively with a similar change in 
urinary potassium excretion.7 
A 20 mmol increase in daily magnesium intake resulted in a diastolic blood pressure 
fall of 3.4 nunHg in a recent trial among Dutch women. I' The mean reduction in blood 
pressure of 7.6 mmHg systolic and 3.3 nunHg diastolic observed in our study, in which 
sodium was lowered by 38 mmol, potassium intake raised by 18 mmol, and magnesium 
intake was estimated to be raised by 7 mmol, was larger than we would expect based on 
these previous estimates. The 95 % confidence interval allows for a fall in systolic blood 
pressure as large as 11 nunHg. 
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Figure 4,3,1 Systolic and diastolic blood 
pressure (BP) at baseline and during 
intervention in controls and subjects in the 
mineral salt group. * 
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Figore 4,3,2 Mean changes in 24 hour 
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Several factors could have contributed to the comparatively large blood pressure effect 
in our study. Firstly, the simultaneous alteration of sodium, potassium, and magnesium 
intake may more strongly affect blood pressure than a change of one mineral alone, To 
our knowledge no double blind, placebo controlled intervention trial on the combined 
effect of these minerals on blood pressure has been reported in humans. However, some 
data on the interaction of sodium and potassium are available. In an observational study 
KIIaw and Barrett-Connor showed a stronger correlation of age adjusted blood pressure 
with the sodium/potassium ratio than with the individual minerals.' This was conftrmed in 
mildly hypertensive young people.' The increased magnesium intake in our trial could 
have contributed to the reduction in blood pressure, possibly through interaction with 
sodium and potassium.",18 Moreover, possibly the unique nature of the mineral salt, 
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characterised by its source and double salt structures, also had a beneficial effect. 
Secondly, the magnitude of the blood pressure fall could be related to the age of our 
study population. There is substantial evidence that elderly people benefit more from a 
reduction in sodium intake than young people.'·l9 We could not show a modification of 
the intervention effects with age, but the age range in our study was restricted. 
There are many deaths from cardiovascular disease in elderly people. Thus a reduction 
in blood pressure as observed in our study potentially has important implications for 
morbidity and mortality in the older population."·2I We could effectively study the 
combined effect of sodium, potassium, and magnesium on blood pressure with a salt 
substitute, leaving the diet unchanged. Replacing common salt with the mineral salt 
Table 4.3.4 Serum electrolyte concentrations at baseline and after 24 weeks of intervention. 
Week Ot 
Sodillm (111111011/): 
Controls 137.1 (0.4) 
Mineral salt group 137.0 (0.5) 
Potassium (11I11101ll): 
Controls 4.17 (0.06) 
Mineral salt group 4.27 (0.04) 
Magnesium (1111110111): 
Controls 0.86 (0.01) 
Mineral salt group 0.86 (0.01) 
Ca/cilllll (1111110/1/): 
Controls 2.44 (0.02) 
Mineral salt group 2.41 (0.02) 
Ionised calcium (mmol/l): 
Controls 1.24 (0.01) 
Mineral salt group 1.24 (0.01) 
Values arc means with standard error in parentheses. 
t Values were missing for seven controls and four subjects in the mineral salt group. 
* Values were missing for eight controls and four subjects in the mineral salt group. 
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135.4 (0.5) 
135.5 (0.4) 
4.23 (0.05) 
4.35 (0.04) 
0.82 (0.01) 
0.83 (0.01) 
2.32 (0.01) 
2.35 (0.01) 
1.19 (0.02) 
1.23 (0.02) 
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resulted in a modest change in the mineral composition of the diet and was well accepted. 
This provides a practicable and more convenient dietary intervention than trying to get 
patients to restrict salt intake or to take a pure potassium chloride salt substitute." 
In conclusion our findings indicate that replacing sodium salt with a low sodium, high 
potassium, high magnesium salt could offer a valuable nonpharmacological approach to 
lowering blood pressure in mild to moderate hypertension, especially in older people. 
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4.4 
Long-term moderate sodium restriction does not adversely affect the 
serum HDLltotal cholesterol ratio 
Introduction 
In severe hypertensive subjects, a clear benefit of sodium restriction on blood pressure 
has repeatedly been shown.l A number of short-term studies, however, have observed an 
adverse effect of salt restriction on the blood lipid profile of normotensive and 
hypertensive subjects.2.3.4.5.6.7.8 In hypertensive subjects, the reduction of blood 
pressure will substantially improve the cardiovascular risk profile and outweigh any 
small, lipid-raising effect of salt restriction. The question, however, remains whether 
sodium restriction could be advocated as a safe health measure to reduce cardiovascular 
risk in the general population. In this respect, attention should primarily be focused on the 
ratio of HDL-cholesterol to total cholesterol as this is considered a better predictor of 
cardiovascular risk than total cholesterol or cholesterol subfractions separately.' 
In a randomised, double blind trial we observed a substantial blood pressure reduction 
of 7.6 mmHg systolic and 3.3 mmHg diastolic when older untreated hypertensive subjects 
moderately reduced their sodium intake and increased their potassium and magnesium 
intake by means of a mineral salt during 24 weeks.lo In this study, we investigated 
whether moderate sodium restriction affected the serum HDLltotal cholesterol ratio. 
Methods 
One hundred men and women age 55 to 70 years with untreated hypertension (systolic 
blood pressure 140-200 mmHg andlor diastolic blood pressure 85-110 mmHg) 
participated in a randomised, double blind trial of the effect of mineral salt on blood 
pressure. During 24 weeks, 49 participants received a mineral salt (sodium:potassium: 
magnesium (mmol)= 8:6:1)* for use at cooking and at the table, and foods prepared with 
the mineral salt. Fifty-one controls received common salt and foods. Participants collected 
two consecutive 24 hour urine samples at baseline and after 8, 16 and 24 weeks of 
intervention for the assessment of sodium and potassium excretion. Blood sampling took 
place at baseline and after 24 weeks of intervention. A detailed description of the study 
has been presented elsewhere. 10 
* SagaSalt~ 
Dutch product name 'Jozo Viraal', distributed by Akzo Nobel Salt Europe 71 
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Population for alia lysis 
Blood serum for measurement of serum total cholesterol and HDL-cholesterol was 
available for 90 of 100 subjects. One control was excluded from the analyses because 
cholesterol lowering medication was started during the trial. This resulted in a total of 46 
subjects in the mineral salt group (94%) and 43 controls (84%) for the present analysis. 
Laboratory measurements 
Blood serum had been stored for approximately two years at -20' Celsius. Analysis of 
serum total cholesterol was performed using an automated enzymatic procedure. ll Serum 
HDL-cholesterol was measured similarly, after precipitation. No data on haematocrit were 
available to adjust findings for changes in plasma volume. Serum total protein is not 
expected to be influenced by the intervention and for this reason, change in plasma 
protein concentration was considered to be a marker of change in plasma volume. For the 
analysis of serum total protein a colorinletric method was used (Hitachi 747 B6hringer). 
Urinary sodium and potassium were measured by flame photometry. 
Data alia lysis 
Changes in serum total cholesterol, HDL-cholesterol and HDLltotal cholesterol ratio from 
baseline were compared between the mineral salt group and controls and tested for 
statistical significance by Student's t test. Adjustment of change in lipids for change in 
serum total protein and potential confounders was performed by analysis of covariance. 
Means and 95 % confidence intervals (95 % CI) of the differences between groups are 
given. P-values below the a-level of 0.05 were considered statistically significant. 
Results 
Baseline characteristics of the study groups are shown in table 4.4.1. No significant 
differences were observed between the groups. After 24 weeks of intervention, 24 hour 
sodium excretion was significantly decreased by 41 mmol (95% CI 23 to 60 mmol, 
p<O.OOI) and potassium excretion significantly increased by 16 mmol (95% CI4 to 28 
mmol, p=O.OI) in the mineral salt group compared with the controls. The changes in 
urinary magnesium and serum total protein during intervention were not significantly 
different between the study groups. In the mineral salt group, mean change in body 
weight during intervention was 0.4 kg more than in controls (p=0.20). This difference, 
though not statistically significant, was still present after 24 weeks. 
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Table 4.4.1 Baseline characteristics of the participants according to study group. 
Controls Mineral salt group 
(n~43) (n~46) 
Males (%) 22 (51) 27 (59) 
Age (yrs) 67.0 (4.5) 65.9 (4.8) 
Blood pressure (nunHg): 
Systolic 157.6 (12.1) 157.4 (15.2) 
Diastolic 91.3 (9.2) 89.6 (9.9) 
Height (em) 167.4 (8.8) 169.5 (9.7) 
Body weight (kg) 75.2 (10.3) 77.3 (6.9) 
Body mass index (kg/m') 26.8 (2.8) 26.9 (3.0) 
Serum: 
Total cholesterol (nunol/I) 7.0 (1.5) 6.9 (1.1) 
HDL-cholesterol (nunolll) 1.11 (0.37) 1.00 (0.20) 
HDLltotal cholesterol ratio 0.16 (0.06) 0.15 (0.03) 
Total protein (g/I) 70.1 (8.2) 70.3 (5.1) 
Urine: 
Sodium (mmol/24h) 136 (48) 143 (51) 
Potassium (mmoI124h) 82 (25) 87 (20) 
Sodium/potassium ratio 1.7 (0.6) 1.7 (0.4) 
Values are means with standard deviation in parentheses, or numbers with percentages in parentheses 
Urinary volumes in both groups were not significantly different and remained stable 
throughout the intervention period. 
Serum total cholesterol at 24 weeks was significantly decreased in both groups, but 
0.37 mm01l1 (95% CI 0.02 to 0.71, p~O.04) more in the controls than in the mineral salt 
group after adjustment for age and sex. Serum HDL-cholesterol was decreased by 0.06 
mmol/I in the controls, and increased by 0.05 mmol/I in the mineral salt group, yielding a 
statistically significant difference of 0.11 mm01l1 (95% CI 0.02 to 0.20, p~0.02). The 
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HDLltotal cholesterol ratio was increased 0.007 units (95% CI -0.006 to 0.020, p=0.25) 
more in the mineral salt group than in the controls (table 4.4.2). 
After further adjustment for changes in potassium excretion, serum total protein and 
body weight during intervention, differences in change of lipids between the mineral salt 
group and the controls were more pronounced (table 4.4.2). Serum total cholesterol at 24 
weeks was decreased 0.45 mmolll (95% CI 0.12 to 0.77 mmolll, p=0.009) in the 
controls compared with the mineral salt group. Serum HDL-cholesterol was increased 
0.14 mmolll (95% CI 0.05 to 0.22 mmolll, p=0.002), and the HDLltotal cholesterol 
ratio 0.010 units (95% CI -0.003 to 0.023, p=0.14) in the mineral salt group compared 
with the controls after adjustment for changes during intervention. 
Discussion 
Recently, concerns have been raised with regard to the health effects of sodium 
restriction. An increased activity of the sympathetic nervous system and elevated levels of 
plasma catecholamines and renin have been observed with sodium restriction. These 
effects are similar to those observed with diuretic therapy, and it has been postulated that 
sodium restriction, like diuretics, could adversely affect blood lipids and thereby the 
cardiovascular risk profile. 12.13,14,15 
In our study, we observed a decrease in total cholesterol level in both the controls and 
the mineral salt group. This could possibly be explained by the change of season, as the 
study started in autumn and ended in spring. A seasonal fluctuation of cholesterol level in 
humans has been reported by others. 16 The decrease in cholesterol may also be a 
concomitant effect of the intervention. Participants in both groups possibly adopted a 
healthier lifestyle or diet during the study period. However, serum total cholesterol 
decreased more in the controls than in subjects who reduced their sodium intake by the 
mineral salt. HDL-cholesterol, on the other hand, increased during moderate sodium 
restriction and this partially explains the lower decrease in total cholesterol in the mineral 
salt group. The HDLltotal cholesterol ratio slightly increased following sodium 
restriction. Therefore, the net effect was an improvement in the cardiovascular risk 
profile for subjects in the mineral salt group. 
The mineral salt group gained less weight during intervention than the controls, which 
may be due to extracellular fluid loss. However, urinary volumes remained stable during 
intervention and were similar in both groups. Furthermore, an increased loss of 
extracellular fluid is likely to be an acute effect of severe sodium restriction and probably 
is no longer present after 24 weeks of moderate sodium restriction. The present study was 
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Table 4.4.2 Change in serum total cholesterol, HDL-cholesterol and HDLltotal cholesterol ratio from baseline in controls (n=43) and 
subjects in the mineral salt group (n=46). 
Week 0 Week 24 Change Adjusted change* 
Total cholesterol (mmol/l) 
Controls 6.9 (0.20) 6.4 (0.16) -0.60 (0.12) -0.63 (0.12) 
Mineral salt group 6.9 (0.19) 6.6 (0.15) ·0.22 (0.12) -0.18 (0.11) 
Differencet 0.37 0.45 
[0.02 - O.71J p=O.04 [0.12 - 0.77] p=O.OO9 
HDl.rcholesterol (mmol/l) 
Controls 1.11 (0.04) 1.04 (0.04) -0.06 (0.03) -O.Q7 (0.03) 
Mineral salt group 1.01 (0.04) 1.06 (0.04) 0.05 (0.03) 0.06 (0.03) 
Difference 0.11 0.14 
[0.02 - 0.20J p=O.02 [0.05 - 0.22J p=O.OO2 
HDUtotal cholesterol ratio 
Controls 0.16 (0.008) 0.17 (0.007) 0.005 (0.005) 0.004 (0.005) 
Mineral salt group 0.15 (0.007) 0.16 (0.007) 0.013 (0.004) 0.014 (0.005) 
Difference 0.007 0.010 
[-0.006 - 0.020J p=O.25 [-0.003 - 0.023J p=O.14 
Values are adjusted f~r age and sex and presented as means with standard errors in parentheses. 
* Additionally adjusted for changes in body weight. serum total protein and potassium excretion during intervention. 
t Difference in change from baseline: mineral salt group compared with controls; with 95 % confidence interval and two-tailed p-value. 
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not a priori designed to study the effect of sodium restriction on the plasma lipid profile. 
Consequently, we had no data on haematocrit, and we used change in senlln total protein 
to adjust for changes in plasma volume. As this is only an indirect measure of change in 
plasma volume, residual confounding cannot be excluded. We therefore do not lUle out 
the possibility that the mineral salt group experienced some volume depletion, which 
could explain the higher serum cholesterol and HDL-fraction levels in this group. The 
results on change in HDLltotal cholesterol ratio, however, are not affected by differences 
in plasma volume between the groups. Comparing changes in HDLltotal cholesterol ratio 
between the groups is therefore more valid than comparisons in total cholesterol and 
HDL-cholesterol separately. Because the HDLltotal cholesterol ratio is a better predictor 
of cardiovascular risk than total cholesterol or cholesterol sub fractions separately, we also 
consider this comparison most relevant to practice. 
Because the salt that we used for intervention contains 41 % potassium chloride and 
17% magnesium salts, subjects in the mineral salt group increased their potassium and 
magnesium intake as well. Data on the effect of potassium on serum lipid concentrations 
are scarce. In rats, serum cholesterol was not significantly affected by a high potassium 
diet. 17 Kjeldsen ef al. studied 50-year-old men on a low sodium diet combined with 
potassium supplementation and did not observe significant changes in serum total 
cholesterol and HDL-cholesterol. 18 Until now, there is no evidence that the moderate 
increase in daily potassium intake of 16 nilliol could have accounted for the changes in 
HDL-cholesterol and total cholesterol in our study. With regard to magnesium, Singh el 
al. in a single-blind, randomised study, reported significant decreases in selUm total 
cholesterol and LDL-cholesterol, and a marginal increase in HDL-cholesterol, when 214 
subjects received a magnesium-rich diet containing approximately 800 mg more 
magnesium than a control diet. 19 Marken el al., on the other hand, in a controlled study, 
did not observe significant changes in the blood lipid profile when 50 healthy volunteers 
were given 800 mg supplemental magnesium for 60 days.'o Similarly, no effect was 
observed in 17 subjects with hypercholesterolaemia andlor hypertriglyceridaemia who 
received 1,785 mg magnesium for 6 weeks.21 Magnesium intake in our study was 
increased by approximately only 170 mg per day in those who used the mineral salt. We 
think that this slight increase in magnesium intake could not have affected selUm HDL-
and total cholesterol levels in our study. 
Several studies examined the effect of a reduced sodium intake on selUm total 
cholesterol and cholesterol subfractions. Ruppert ef al. demonstrated significantly higher 
levels of serum total cholesterol and LDL-cholesterol during one week of severe sodium 
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restriction to 20 mmol per day in normotensive adults.' Similar findings were reported in 
a small study among normotensive and untreated hypertensive men. Again, sodium intake 
was strongly reduced to 20 mmol per day.' These findings were confirmed by Sharma et 
af. who showed an increase in total cholesterol and LDL-cholesterol during a low sodium 
regimen of 20 mmol per day in 15 young, normotensive men.' In all studies, change in 
plasma volume was taken into account and the reported increases in lipids were not 
regarded to reflect haemoconcentration. Regrettably, none of the studies reported data on 
change in HDLltotal cholesterol ratio, thereby making a true comparison with our study 
impossible. 
The majority of studies on sodium restriction and serum cholesterol levels focused on 
short-term effects of a low-salt diet. However, long-term rather than short-term effects 
are relevant to practice. In Qur study, participants reduced their sodium intake for 24 
weeks. No adverse effect on the HDLltotal cholesterol ratio was observed. Our findings 
are confirmed by a 6-month study by Oberman ef af. who showed no effect of a mild 
reduction in sodium intake, combined with a small increase in dietary potassium, on total 
cholesterol in untreated hypertensive patients. 22 Analogously, diuretic therapy does not 
seem to adversely affect serum lipids in the long-term. The Hypertension Detection and 
Follow-up Program observed an initial increase in total cholesterol with diuretic use 
during the first year, but during subsequent annual follow-up total cholesterol decreased 
below baseline levels.23 The Framingham Study neither showed an increase in total 
cholesterol after a few years of diuretic use. 24 
Substitution of common sodium salt by a low sodium mineral salt appeared to be a 
feasible means for lowering blood pressure in older, untreated hypertensive subjects. A 
long-term moderate reduction in sodium intake was easily achieved by the mineral salt. 10 
From our findings we conclude that long-term moderate sodium restriction does not 
adversely affect the cardiovascular risk status of the older hypertensive patient. 
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GENERAL DISCUSSION 
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General discussion 
Introduction 
The limitations and merits of the individual studies described in this thesis have already 
been discussed extensively in the previous chapters. In this chapter, first a general 
overview will be given on blood pressure development during life. Subsequently, the role 
of sodium and potassium intake in determining blood pressure level and change will be 
discussed, implementing the findings of the studies described in this thesis. In the second 
part of the discussion, methodological aspects of the studies will be discussed. Finally, 
directions for further research will be delineated. 
Blood pressure development during life 
Hypertension is an important risk factor for heart disease and stroke. In Western 
societies, blood pressure levels increase consistently during the course of life.' Judson 
and Nicholson, in 1914, were the first to report that the rise in blood pressure already 
starts in childhood.2 This rmding has repeatedly been confirmed by others in the years 
thereafter.' In Dutch youngsters, an average yearly change of 2 mroHg in systolic and 1 
mroHg in diastolic blood pressure is observed from birth until the age of 20 (fig 5.1).' 
The rise in blood pressure is strongly related to growth and maturation.' During puberty 
systolic blood pressure rises more sharply in boys than in girls, due to the difference in 
age at which maturation is achieved. The rise in blood pressure becomes less pronounced 
after the age of 20. Throughout adult life, blood pressure increases slowly but steadily. 
At the age of 55, diastolic blood pressure achieves a plateau and tends to decrease with 
advancing age. Systolic blood pressure level keeps increasing at older age. There is 
reason to believe that the roots of hypertension are to be found in childhood, or even in 
infancy.- Growth-promoting processes, probably involving neuroendocrine mechanisms, 
may both elevate blood pressure and stimulate somatic growth and maturation in 
children.' Genetic and enviromnental factors may interact with these processes and 
influence the rise in blood pressure in childhood. A blood pressure level that is 'set' in 
adolescence may be carried forward in adult life by a self-perpetuating process.'" In line 
with this hypothesis, it has been shown that subjects who experienced the largest rise in 
blood pressure at young age were most likely to develop hypertension later in life.' 
Blood pressure, as most other physiological parameters, is normally distributed within a 
population. The dividing line between 'normotension' and 'hypertension' is arbitrary, and 
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Figure 5.1 AgeH and sexHspecific average levels of systolic and diastolic blood pressure. * 
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more or less reflects the level of blood pressure where, in general, the benefits of 
treatment with antihypertensive drugs exceed the costs and potential adverse effects of 
therapy. JO 
Electrolytes and blood pressure 
Sodium 
Ambard and Beaujard, in the beginning of tlus century, were the first researchers who 
related the intake of salt to blood pressure in hypertensive patients,'! At the same time, a 
number of clinical and animal experiments were published by others who related salt 
intake to febrile illness, cardiac failure, edema and several other kind of illnesses. 
Kempner in the 1940s developed a rice-fruit diet, low in sodium and high in potassium, 
which appeared successful in lowering blood pressure in malignant hypertension. 12 
Epidemiologic research already began in 1927 with a study by Thomas, who related 
salt intake to the prevalence of hypertension in Greenland Eskimos. I3 From that time on, 
a large number of studies linking the salt intake of populations with the incidence or 
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prevalence of hypertension have been performed. It was noted that hypertension is 
virtually nonexistent in unacculturated societies with a low salt intake, and that blood 
pressure does not increase with age in these populations. Dahl, in 1960, presented a graph 
that indicated an almost perfect linear relationship between the prevalence of hypertension 
and salt intake among five separate populations around the world." However, this study 
was hampered by severe methodological shortcomings: some populations were 
represented by only a small number of individuals, estimates of salt intake were not 
unifonn, and no adjustments were made for differences in age and sex distributions. In 
the 1980s, a large international epidemiologic study (INTERSALT) was initiated to 
overcome these problems." The INTERSALT study describes the relation between 
standardised measurements of blood pressure and 24 hour urinary sodium and potassium 
excretion in over 10,000 individuals at 52 centres around the world. The study showed 
that a 100 mmol/day difference in sodium intake is associated with a 2.2 nullHg differen-
ce in systolic blood. pressure. Tllis relation, however, was lost when four primitive 
societies with an extremely low salt intake were omitted from the analyses. Interestingly, 
however, sodium intake was related to the age-related slope of blood pressure also when 
the analysis was restricted to the 48 relatively high-salt centres. A 100 mmol/day lower 
sodium intake was associated with a 9 nunHg lesser rise in systolic blood pressure 
between the ages 25 and 55." 
Most epidemiologic studies within single populations have not been able to show a 
relation between sodium intake and blood pressure. 17 This could reflect inaccurate 
assessment of sodium intake or blood pressure,18 or be due to the fact that the range of 
salt intake within a single popUlation is too restricted to adequately study the effect of 
high and low intakes on blood pressure. Habitual sodium intake in Western populations 
varies between 100 and 250 mmol (6-15 grams of salt) per day.19 Sodium intakes below 
50 mmol per day are observed in primitive societies.15 Possibly, the threshold above 
which sodium may start to affect blood pressure is somewhere between 50 and 100 nuno!. 
Studies that do not include intakes both below and above the threshold level may therefore 
fail to demonstrate an effect of sodium on blood pressure. An alternative explanation for 
the lack of an association could be that a population consists of a heterogeneous group of 
individuals, whose blood pressures may react quite differently to dietary influences. 
Evidence is now accumulating that there are subgroups who are more sensitive to the 
effect of sodium on blood pressure than others.,o.2I.".23 Accordingly, in intervention 
studies of the effect of sodium restriction or supplementation 011 blood pressure, a large 
heterogeneity of blood pressure response has been observed: some people experience a 
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blood pressure reduction, whereas others do not respond or even show an increase in 
blood pressure."'" However, part of the variability in response is random and has no 
biologic significance." Persons whose pressures increase with a high sodium intake and 
decrease with a low sodium intake have been termed salt-sensitive. The issue of salt-
sensitivity will be discussed in more detail later on in this chapter. 
Potassium 
An alternative explanation for the low blood pressure found in populations with a low 
dietary sodium intake is their generally high intake of potassium. Several epidemiological 
studies have pointed to an inverse relationship between potassium and blood 
pressure.26•27 The INTERSALT study showed a decrease of 2.5 mmHg in systolic 
blood pressure, and a 1.7 mmHg decrease in diastolic pressure per 100 mmol increase in 
potassium intake across 52 centres around the world. In older subjects of the Rotterdam 
Study, we demonstrated a decrease in systolic pressure of 9.4 mmHg, and a decrease in 
diastolic pressure of 4.9 mmHg per 100 mmol potassium (Chapter 4.1). In a meta-
analysis of 19 trials, Cappuccio and MacGregor reported an average fall in supine blood 
pressure of 5.9 IruuHg systolic and 3.4 mmHg diastolic with a substantial experimental 
average increase in potassium intake of 86 mmol per day." Not all clinical trials, 
however, were able to demonstrate an effect of potassium supplementation on blood 
pressure.29•30 The blood pressure lowering effect of potassium has been attributed to an 
induced natriuresis, altered activity of the renin-angiotensin-aldosterone system and/or 
kallikrein-kinin system, or to a modulation of the sympathetic nervous system activity and 
alteration of the peripheral resistance.3I·31.33.34.35 The effect of a high potassium 
intake on blood pressure is more pronounced in blacks than in whites, in individuals 
consuming a high sodium chloride diet, and in hypertensive persons. ".36.37 The 
INTERSALT study additionally showed stronger associations of potassium with blood 
pressure with increasing age.38 
Electrolyte interaction 
The renal handling of sodium and potassium is closely related, which argues for a 
concomitant consideration of these cations when studying their effect on blood pressure. 
The effects of a high sodium intake on blood pressure may be amplified by dietary 
deficiencies of potassium. In the NHANES I study, the sodium/potassium ratio was more 
strongly related to blood pressure than sodium and potassium alone." Significant 
interactions between sodium and potassium have also been reported in studies by 
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others. 40•4l The study described in Chapter 4.3 of this thesis shows the effect of a 
moderate reduction in sodium intake and a moderate increase in potassium and 
magnesium intake on blood pressure in men and women aged 55 years and over. This 
simultaneous change in mineral intake resulted in a substantial, significant fall in systolic 
and diastolic blood pressure. The blood pressure effect was 3 to 4 times larger than 
expected on the basis of previous tdals of either sodium restriction or potassium 
supplementation alone. Tllis could be due to interaction between sodium and potassium. 
The increased magnesium intake of 7 mmol (168 mg) per day, resulting from use of the 
mineral salt, may have contributed to the relatively large reduction in blood pressure. A 
blood pressure lowering effect of magnesium has been reported in some observational and 
experimental studies, but results are inconsistent. 42,43,44 Several studies pointed to a 
possible interaction between sodium, potassium, and/or magnesium in determining blood 
pressure level." Magnesium has been shown to be a modulator of sodium-potassium ion 
transport in numerous tissues. 46•47 The results of the mineral salt trial reported in this 
thesis suggest that multiple intervention on intake of several minerals may be more 
effective than changing the intake of sodium, potassium, or magnesium individually. 
However, because of the design of the trial interaction effects could not be studied. In our 
cross-sectional data (presented in Chapter 4.2) we could neither adequately study whether 
minerals interact, because the dietary intakes of minerals were too strongly 
intercorrelated. The methodological problem that arise in nutritional data analysis will be 
discussed later on. 
Susceptibility 
Markers of susceptibility 
Hypertension is often considered to be a homogeneous condition, However, evidence is 
accumulating that there are several subtypes of hypertension with different 
pathophysiological and haemodynamical characteristics.48 An intervention that could 
lower blood pressure in one subtype of hypertension may have no effect in other 
subtypes. For optimal treatment it seems worthwhile to identify subgroups of people who 
are likely to respond favourably to a specific intervention. Genetic factors could be 
related to the sensitivity of blood pressure to sodium andlor potassium intake. For 
example, several gene variants that give rise to higher levels of angiotensinogen have 
been observed more frequently in hypertensives than in normotensives. Raised levels of 
angiotensinogen could lead to overactivity of the renin-angiotensin system in response to 
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salt intake.49 Carriers of the variant genes may therefore be more likely to benefit from 
sodium restriction than others. Several other variables, such as urinary kallikrein 
excretion, intracellular sodium concentration, sodium-lithium countertransport, and 
sodium-potassium cotransport have also been related in some way to sodium or potassium 
metabolism, or both.'''' Studies in this field may help to improve the understanding of 
a possible inherited susceptibility to hypertension resulting from an inadequate intake of 
sodium and/or potassium. 
Besides genetic factors, physiological or pathological alterations in the cardiovascular 
system may increase the sensitivity of blood pressure to sodium andlor potassium. These 
changes could be related to age, blood pressure level itself, or other factors. Besides 
neural vasomotor control mechanisms,52 hormonal systems involved with salt and water 
balance alter with age. 53 The number of functional nephrons in the kidney has been 
shown to be reduced at older age. This may lead to an increased delivery of sodium to 
the macula densa in surviving nephrons, resulting in an inhibition of renin synthesis and 
secretion by the juxtaglomerular cells. 54 The renin-angiotensin system plays a major role 
in the water and sodium balance, and its major function is to allow wide variations in 
sodium intake and excretion without large fluctuations in blood pressure. If the renin· 
angiotensin system becomes less responsive, blood pressure rises when large amounts of 
sodium are ingested to maintain sodium balance via pressure natriuresis. Sustained 
hypertension has been shown to induce structural changes in blood vessels, heart, and 
kidney. 55 Again, damage of renal tissue may affect the renin-angiotensin system, which 
could increase the sensitivity of blood pressure in hypertensives to intake of electrolytes. 
An increased sensitivity of blood pressure to sodium intake with age and blood pressure 
level was confirmed by a meta-analysis of intervention trials by Grobbee and Hofman." 
In the next paragraph, blood pressure response to intake of sodium andlor potassium in 
different age groups will be discussed in more detail. 
Susceptible tillle periods ill life 
Experiments in genetic strains of salt-sensitive rats have shown that a high salt intake at 
the time of weaning could have a major impact on the early development of 
hypertension. 56 Similarly in humans, exposure to high sodium levels in infancy may 
adversely affect the development of blood pressure during growth and maturation. In 
Chapter 2 of this thesis special attention has been paid to sodium intake in infancy in 
relation to blood pressure in adolescence. The original trial on which the follow-up study 
was based showed a positive relationship between sodium intake and blood pressure 
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development during the first six months of life. The follow-up study showed that higher 
blood pressure levels were still present 15 years later ill children who had been assigned 
to the diet that contained the usual amount of salt. Sodium may have played a critical role 
in early blood pressure development in these children, possibly through an adverse effect 
on immahlre kidney tissue.57 An alternative explanation could be that the preference for 
a certain level of salt intake is set early in life and maintained thereafter, eventually 
resulting in higher blood pressure levels. From our study we cannot infer which etiologic 
factors may have been involved in the blood pressure rising process. McGarvey el al. 
observed an independent, inverse relation between maternal prenatal potassium intake and 
infant diastolic blood pressure at 6 and 12 months, which provides evidence for a very 
early role of potassium in blood pressure regulation." In the follow-up study of infants 
mentioned above, potassium intake was not taken into account as the difference in sodium. 
intake resulted from random allocation. Data on the relation between nutrient intakes in 
infancy and future blood pressure are scarce. Studies in this field may provide clues for 
the prevention of hypertension and a further understanding of its causes. 
As discussed previously in this chapter, the age-related blood pressure rise is most 
pronounced in children. As the result of a possible self-perpetuating process of blood 
pressure level on blood pressure, small differences in rate of blood pressure change in 
childhood lllay yield substantial differences in blood pressure level later in life.'·8 Studies 
on determinants of blood pressure development at young age are therefore of particular 
relevance. In Chapter 3 the relation between sodium and potassium intake and rate of 
blood pressure change was studied in a follow-up study among children aged 5 to 19 
years. Change in blood pressure was assessed in two time periods, i.e. between 1978 and 
1985 ('early phase') and between 1986 and 1991 (,late phase'). The relation between 
mean urinary electrolyte excretions in the early phase and blood pressure changes in both 
the early phase (Chapter 3. I) and late phase (Chapter 3.2) was studied. The associations 
with change in blood pressure appeared to be stronger for potassium than for sodium in 
both the early and late phase of the study. This finding corroborates the report by Lever 
el al. who hypothesised that in the early stages of hypertension blood pressure is raised 
by a process more closely related to potassium than to sodium." 
The elderly is of particular interest in light of the sodium-blood pressure relation. A 
number of physiological alterations occur when people grow older, making them particu-
lar susceptible to a high intake of salt. 60•61 •62•63 Low plasma renin levels, a decreased 
renin response to stimulation, and volume expansion have repeatedly been demonstrated 
in older people. 64 Besides a reduction of functional neurons leading to an inhibition of 
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renin synthesis, as discussed in the previous section, the decline in plasma renin levels 
with age may be explained by a decrease either of renin storage or of sympathetic 
nervous system activity on renin release. 65 The cross~sectional study, reported in 
Chapter 4.1, suggests a positive association of sodium excretion and an inverse 
association of potassium excretion with blood pressure in people above 55 years of age. 
The observed association between electrolyte excretion and blood pressure was probably 
underestimated, because electrolyte intakes were assessed by a single overnight urine 
collection and hypertensive subjects were excluded from the analysis. In Chapter 4.2 
intakes of electrolytes were estimated from a semiquantitative food frequency 
questionnaire. Potassium intake again was inversely related to blood pressure. Intake of 
sodium was not measured in this study. The intervention study described in Chapter 4.3 
showed that blood pressure in older, mildly hypertensive subjects is sensitive to multiple 
changes in mineral intake. 
Intervention 
Target groups for intelwntioll 
As indicated in Chapters 2 and 3 of this thesis, the roots of hypertension may be found in 
childhood. Children who experience a large rise in blood pressure are more likely to 
develop hypertension in later life.' Intervention at (very) young age with the aim to 
prevent or diminish the age-related rise in blood pressure could therefore yield a 
significant contribution to the prevention of hypertension. 
In adults, higher blood pressure levels have been associated with an increased mortality 
due to heart disease and stroke. The combined results of nine prospective studies, 
generally among middle-aged men, show that the relative risk for a heart attack is more 
than twice as high for diastolic blood pressures above 105 ounHg compared to pressures 
of 90 nunHg, and almost four times as high compared to pressures of 80 nunHg. The 
relative risk for stroke increases even more dramatically with blood pressure level.66 
Once hypertension has developed, it tends to be self-perpetuating via amplifying 
mechanisms, mediated by secondary structural changes in the blood vessels, heart, and 
kidney. Lowering blood pressure, also of mildly elevated levels, leads to a decrease in 
coronary heart disease and stroke in middle-aged adults."'" Intervention on blood 
pressure level and change in hypertensive adults is likely to prevent or delay end organ 
damage. A decrease in blood pressure in mildly hypertensive and nomlOtensive adults will 
probably result in a reduction of the cardiovascular risk and may prevent a future rise in 
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blood pressure. A clear benefit in total and cardiovascular mortality of blood pressure 
reduction has been shown also in older, hypertensive people below the age of 70.80.69 
With respect to the very old, however, there is debate about whether blood pressure 
reduction should be advocated or not. 70.71.72.73 
IlIIervention approaches 
With regard to the prevention of cardiovascular complications, two main intervention 
approaches are generally considered. The 'high risk' approach aims at lowering blood 
pressure specifically in individuals at an increased risk for cardiovascular disease, as 
judged by their blood pressure levels. In this approach, hypertensive patients within the 
population are identified and treated. This approach is of large benefit to the individual 
because a reduction in blood pressure will substantially reduce the patient's cardiovascular 
risk. On the other hand, 60% of cardiovascular complications occur in people with 
diastolic blood pressure levels below 95 nunHg." In other words, the burden of 
cardiovascular disease occurs predominantly in people with only mildly elevated blood 
pressure levels who do not easily come to the attention of the medical care system. The 
prevalence of severe hypertension in the general population is low, whereas that of mild 
hypertension is much higher. Consequently, if significant reductions in cardiovascular 
disease rates in the community are to be achieved, attention should be paid to reduction of 
blood pressure in the large group of mild hypertensives." The 'whole population 
approach' aims at shifting the distribution of blood pressure levels to lower levels in the 
community as a whole. The community benefits of lowering the average blood pressure 
have been estimated by Wilkins and Calabrese.'· In white US males aged 35 to 75, a 5 
nunHg reduction in systolic blood pressure would reduce the number of major coronary 
events by approximately 35,000 per year. 
The 'whole population approach', but also the 'high risk approach' when judging blood 
pressure levels only, disregard the fact that a population consists of a heterogeneous 
group of individuals. The mechanisms involved in blood pressure elevation may differ 
across subgroups. As a consequence, the blood pressure response to a specific 
intervention will differ among individuals with a different etiology of hypertension. For 
optimal treatment (and possibly also from the viewpoint of cost·effectiveness), it is 
worthwhile to identify groups of people who are likely to respond favourably to a specific 
intervention. A preventive strategy focusing for example on specific age groups might be 
considered. In case that susceptibles cannot readily be identified within a population, 
screening for indicators of susceptibility will have to take place. The practical 
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implications of this strategy need more detailed consideration. 
Die/my in/e!vellIioll 
One of the most important potentially modifiable determinants of blood pressure is the 
diet. This thesis focuses on the role of mineral intake in blood pressure regulation. 
Chapter 2 showed that the blood pressure levels in adolescence could in part be 
detelmined by the amount of salt in baby food. Reducing salt intake in infancy is a 
measure which can easily be achieved with help of the food industry and which is not 
expected to impair the quality of life or affect other important metabolic or physiologic 
mechanisms in these young children. We did not study the effect of potassium in this 
cohort of infants, but others have suggested that potassium may have a favourable effect 
on blood pressure at very young age," as has been discussed previously in this chapter. 
Lifestyle modifications in other age groups are more difficult to achieve and complian-
ce could be poor in the long-term. This is especially the case if the subject does not (yet) 
experience health problems or is unaware of being at increased risk for cardiovascular 
disease. As demonstrated in Chapters 2 and 3 by the high urinary sodium/potassium ratios 
of around three to four, the diets of children and young people tend to be dominated by 
processed foods high in sodium, and are low in potassium-rich foods such as fruits and 
vegetables. It would seem prudent to move towards a lower sodium/higher potassium diet 
for children, as already advocated for adults,77 for the primary prevention of high blood 
pressure and hypertension in later life. In older people also, the ratio of sodium to 
potassium in the diet of around two to three is substantially larger than the preferred level 
of one. Substitution of common sodium salt by a low sodium, high potassium, high 
magnesium mineral salt offers an effective and feasible approach to lowering blood 
pressure in older people as has been shown in Chapter 4.3. Furthermore, this mild dietary 
intervention did not adversely affect the blood lipid profile (Chapter 4.4). Changing the 
sodium/potassium balance in the diet by means of a salt substitute has not yet been 
studied in infants and children, but could be a useful measure also in these age groups to 
attenuate the rise in blood pressure. 
Phanllacoiogicai or lIollpharmacoiogicai Irealmelll? 
According to the Dutch guidelines for general practitioners, patients with a diastolic 
pressure above 105 mmHg should be treated with blood pressure lowering medication. 
Patients with diastolic blood pressures between 100-104 mmHg should receive treatment 
in case several other risk factors are present. 78 In subjects with clearly elevated blood 
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pressure levels, i.e. diastolic blood pressures above 105 mmHg, the benefits of drug 
treatment clearly outweigh their potential negative side-effects and there is little discussion 
whether the administration of drugs to these patients is acceptable or not. However, in 
patients with high-normal or mildly elevated blood pressure levels, i.e. diastolic blood 
pressures between 90 and 105 mmHg, the need for drug therapy is still subject to 
debate. 79•80 The potential benefits of antihypertensive therapy in mildly hypertensive 
individuals, which in absolute teffils are smaller than in subjects with severe hypertension, 
may be offset by the occurrence of side-effects and the inlpaired quality of life. 81 
Nonphannacological therapy, including weight reduction, dietary interventions, use of 
nutrient supplements, limitation of alcohol intake, regular moderate exercise, and 
relaxation therapy, are possibly preferable in mild hypertension.82 Also in severe 
hypertension, the use of one or more nondrug therapies could be considered as an adjunct 
treatment to antihypertensive medication. 83.84,85 Because of the diminished clearance 
capacity of the body, the elderly could be especially susceptible to unfavourable side-
effects of drugs. Furthermore, older patients are more likely to be under drug treatment 
for coexisting diseases and therefore at higher risk for adverse drug interactions. 
Treatment of high blood pressure in this age group by nonphannacologic means deserves 
even more attention than in younger patients. 86 However, one should be careful that 
long-term nonpharmacological therapy does not lead to suboptimal prevention of 
cardiovascular complications. ll7 Through dietary and other lifestyle modifications, 
diastolic blood pressure is often lowered to levels between 90 and 100 rmnHg and drug 
use is avoided. Prevention in tltis case, however, is not optimal as blood pressure remains 
too high. As for drug therapy, the target diastolic blood pressure level should be below 
90 rmnHg. If this cannot be acltieved by single lifestyle modifications, multifactorial 
intervention could be applied and drugs added if necessary. 
Little is known about the efficacy of pharmacological compared to nonpharmacological 
therapy in mild hypertension. Only few studies have directly compared the effect of drugs 
with nonpharmacoiogicai measures on cardiovascular risk status. 88,89,90,91 The 
evidence from these trials is not conclusive. With regard to blood pressure, reductions 
achieved by lifestyle modifications seem somewhat smaller than those observed with drug 
treatment. In our mineral salt trial presented in Chapter 4.3, diastolic blood pressure was 
reduced by 3-4 mmHg. Moderate weight loss (of about 4 kg) has been shown to lower 
diastolic blood pressure by 2-3 rmnHg in subjects with high-normal blood pressure in the 
Trials of Hypertension Prevention.9l Mean reductions of 5-6 rmnHg in diastolic blood 
pressure are generally achieved with antihypertensive drugs. 68 However, anti-hypertensive 
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drugs, though generally effective in lowering blood pressure, could adversely affect the 
serum lipid profile and other metabolic indices.89.<O,93 When taking these undesirable 
effects into account, the overall effect on cardiovascular risk status in mild hypertension 
may not be very much different between both therapies. 
Methodological aspects 
Introductioll 
In this part of the general discussion, a few methodological problems will be considered 
that were encountered in the studies described in this thesis. The topics that are 
subsequently dealt with are: the effect of measurement errors on the observed associations 
of urinary electrolyte excretions with blood pressure, the study of blood pressure status 
compared to blood pressure change, etiologic versus pragmatic studies, and 
multicollinearity and energy-adjustment in nutritional research. 
Measurement errors of urillary electrolyte excretion and blood pressure 
In the cross sectional study reported in Chapter 4.1 of this thesis, we observed only a 
weak association of sodium with blood pressure after adjustment for potassium excretion. 
From this one may conclude that sodium intake is of little importance in relation to blood 
pressure. However. measurement errors may have affected the observed associations in 
our study and should be considered as an alternative explanation, as discussed below. 
In Western populations, intake of salt within an individual shows a large day-to-day 
variation. Habitual sodium intake of an individual cannot accurately be assessed by a food 
frequency questionnaire, because salt use during cooking and dining is hard to quantify 
and not all salt is actually consumed. More than 90% of the ingested salt is excreted in 
urine within the nextfew days. Urinary excretion of sodium is therefore often used as the 
proxy of intake in epidemiologic studies, even though this relates only to recent intake. 
Because of the difficulties in the assessment of sodium intake, individuals are often 
grossly misclassified with respect to their true habitual sodium intake. In our large 
population study, participants collected one overnight urine sample from which daily salt 
intake was estimated. Overnight urinary values show a moderate degree of correlation 
with 24 hour excretions, but are a crude measure of habitual sodium intake. The 
inaccurate assessment of sodium intake in our study has probably lead to misclassification 
and biased the regression coefficients towards zero (,regression-dilution')." The 
quantitative estimates of the sodium-blood pressure relation could be considerably 
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improved by a more accurate assessment of sodium intake. Multiple 24 hour urine 
samples, collected over a longer period of time and checked for completeness, will yield 
considerably better information than the single overnight urine collection that we used in 
our study. Some techniques are available to adjust for the regression dilution bias."·" We 
did not apply these techniques in our analysis because subjects collected only one urine 
sample, but they are worth being considered. The relation of urinary potassium excretion 
with blood pressure in our study was relatively strong when compared to sodium. If 
potassium intake is less variable than sodium intake, this rmding could in part be 
explained by the smaller measurement error. 
Blood pressure, as other physiological characteristics, is subject to variation. The blood 
pressure within a single individual may vary in different seasons, from day to day, and 
even at different tinle points during the day. Besides that, the ambient temperature, blood 
pressure observer, measuring device, size of the cuff, posture of the subject (sitting, 
standing or lying), as well as the subject's mental and physical state, could influence the 
outcome of the measurement. From this it follows that it is impossible to reliably assess a 
person's blood pressure by a single blood pressure reading. In the Rotterdam Study blood 
pressure was measured twice on one occasion with a random-zero sphygmomanometer, 
and the average was used in our cross sectional analyses reported in Chapters 4.1 and 
4.2. The participants had been sitting quietly for at least 5 minutes before the 
measurements were performed. Nevertheless, these measures did not completely remove 
random error in the assessment of the subjects' blood pressure levels. This will have 
caused imprecision in the estimated effects, resulting in relatively wide 95% confidence 
intervals. Multiple measurements on several separate occasions, preferably over a longer 
period of time, could further reduce the random variation and provide a more reliable 
estimate of the true individual blood pressure levels. However, this appeared not feasible 
in our large population study among elderly people. 
Blood pressure: level verslls change 
In a randomised intervention study, the effect of an experimentally achieved exposure on 
blood pressure is studied. The main end point for analysis in such study is usually change 
in blood pressure due to the exposure. The blood pressure level at the end of the trial will 
be the result not only of blood pressure change due to intervention, but also of several 
factors unrelated to the intervention that may have existed before the start of the study. 
For this reason, in the mineral salt trial described in this thesis (Chapter 4.3) the main 
focus was on change in blood pressure during intervention. The time structure of an 
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etiologic study differs from that of an intervention study. The exposure of interest is not 
introduced at baseline and will probably have existed for a shorter or longer period before 
the start of the study. Whether to study blood pressure level or blood pressure change in 
an etiologic study depends on the exposure at issue and the research question. A stable 
exposure that has been present for a longer time, but that no longer affects current blood 
pressure change (for example a genetic factor that determines blood pressure early in life) 
can only come to the attention when studying blood pressure level. This would argue for 
the choice of level rather than change as the end point in data analysis. In the study 
among children described in Chapter 3, blood pressure change was chosen as the study 
outcome for the following reasons. The major part of the lifetime increase in blood 
pressure occurs in childhood, and it is likely that detenninants of the blood pressure 
increasing process can be identified in particular during this period of life. Furthermore, 
change rather than actual blood pressure in children may be a predictor of adult blood 
pressure and of hypertension."" We did not examine the association of change in blood 
pressure with change in electrolyte excretions over time. Values for urinary sodium and 
potassium appeared to be relatively constant within individuals during the follow-up 
period, and for this reason we averaged electrolyte excretions over the whole time span 
and used this measure of cumulative exposure. 
The study described in Chapter 2 had initially been set up as a randomised trial. 
Because of the differential selection of subjects for the follow-up study, the randomisation 
was lost. It is therefore more appropriate to consider the follow-up study described in this 
chapter as an observational (cohort) study, in which the exposure of interest is an 
experimentally manipulated difference in sodium intake early in life. Blood pressure level 
at 15 years of age, rather than change in blood pressure from birth to adolescence, was 
chosen as the end point. The main reason for this was the different procedure for blood 
pressure measurement in the first and late part of the study. Whereas the early 
measurements had been perfonned with a Doppler device attached to a random-zero 
sphygmomanometer, the latter measurements were performed with a automatic blood 
pressure measuring device. This may be one of the reasons that blood pressure at birth 
appeared to be only weakly correlated to blood pressure in adolescence in this cohort. 
The use of achieved blood pressure level was therefore preferable to the use of blood 
pressure change as the end point in the analysis of tItis study. 
In later life, changes in blood pressure become less pronounced. Probably, stable risk 
factors that have been present for a long time do no longer cause large changes in blood 
pressure in adulthood. Therefore, for a number of determinants one may decide to study 
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their effect on blood pressure level rather than change. Different rates of blood pressure 
change early in life will eventually result in different blood pressure levels in later life. 
Blood pressure level at older age could be considered the cumulative endpoint of lifetime 
blood pressure change. In Chapters 4.1 and 4.2 of this thesis electrolyte intake was 
studied in relation to blood pressure level in a population aged 55 and over. The study of 
blood pressure level becomes more complicated in the very old. In this age group, the 
cardiovascular disease process itself may cause a decline in blood pressure. Consequently, 
blood pressure level in the very elderly is the result of different processes with their own 
specific determinants that have been acting for a longer or shorter period of time. As 
these factors cannot easily be disentangled, the study of blood pressure change is to be 
preferred to blood pressure level. 
Eti%gic verslls pragmatic studies 
The objective of the study has bearings on its design. When studying determinants of 
blood pressure to come to a better understanding of the etiology of hypertension, one may 
often wish to directly link the findings of the study to biological mechanisms. Intervention 
studies designed for this purpose aim to study the solitary effect of (change in) a 
determinant on the outcome. Extraneous effects related to intervention are not of interest 
and should, in fact, be excluded. These effects may therefore be avoided, or be equally 
distributed over the study groups so that they differ with regard to the determinant only. 
In trials, comparability of extraneous effects can be increased by 1) the inclusion of a 
placebo-control group, and 2) blinding of the observer and the participant towards the 
assigned intervention. In nutritional research, one could either study foods or individual 
nutrients as the determinant of interest. Foods are a mixture of numerous compounds and 
it is difficult to relate intake of individual nutrients directly to possible biological 
pathways. Therefore, in etiologic studies total intakes of individual nutrients derived from 
the foods or. alternatively. total 24 hour urinary excretions are mostly the detenninant of 
interest. 
In a pragmatic study the aim may not primarily be to come to a better understanding of 
etiologic factors involved in the disease process, but to estimate the change in the disease 
status itself with a given change in diet. The intervention itself is guided by what can be 
achieved in practice. In pragmatic studies, issues such as long-term feasibility of the 
intervention receive considerable attention. Dietary regimens and combined interventions 
are often studied rather than single nutrients. An advantage of studying foods in stead of 
individual nutrients is that they are in general mOfe directly translated to dietary 
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recommendations. In the intervention study presented in Chapter 4.3, a simultaneous 
change in dietary intake of sodium, potassium, and magnesium was achieved by means of 
a salt substitute. From this study we could not conclude whether it was the decreased 
intake of sodium, the increased intake of potassium or magnesium, or the combined 
changes in mineral intake that accounted for the observed fall in blood pressure. For this 
reason, the study contributes little to the understanding of the mechanisms of blood 
pressure reduction in the hypertensive elderly. On the other hand, the study is highly 
pragmatic in the sense that the results can be easily translated into practical, dietary 
guidelines. 
Multicollinearity and energy-adjustment in nutritional research 
A problem may arise in nutritional epidemiologic research when the intake of nutrients is 
highly intercorrelated. Potassium and magnesium, for example, are often ingested 
together through the same vegetables and fruits. Furthermore, a diet that includes many 
salty foods is often an 'unhealthy' diet that contains fewer potassium- and magnesium-rich 
foods. High intercorrelations of nutrients make it difficult to estimate the impact of one 
single nutrient on blood pressure. In statistical data analysis, the simultaneous inclusion of 
strongly correlated variables in a multivariate model may give rise to unanticipated, 
spurious results. This problem of lIIulticollinearity occurs when the residual variation in 
one of the nutrients is substantially reduced because of the inclusion of one or more other 
nutrients. 9S In case that there is little variation left for the estimation of the regression 
coefficient for the nutrient of interest, no reliable estimate can be obtained. When 
studying electrolyte intake and blood pressure this is for example the case when dietary 
potassium and magnesium are included in the multivariate model together with intake of 
calcium and fibre. The problem of multicollinearity cannot adequately be solved by 
statistical methods as it is due to a lack of variation in the study base. Disentangling the 
individual contributions of highly correlated nutrients on blood pressure is therefore a true 
challenge, if not impossible, in the analysis of cross-sectional data of epidemiologic 
studies. Better information will be obtained by intervention studies, in which the effect of 
individual mineral intakes on blood pressure can truly be compared with the effect of 
combined intakes in parallel groups. People consume foods, not nutrients. Therefore, 
inference from observational studies can probably best focus of mixtures of nutrients 
rather than on individual factors. 
The consumption of nutrients is positively related with total energy intake and 
individual differences in caloric intake may produce variation in intake of nutrients 
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unrelated to dietary composition. Total caloric intake may be a primary detenninant of 
disease and it is therefore desirable to adjust electrolyte intakes for total energy to avoid 
confounding. In case that total caloric intake is not related to the study outcome, 
adjustment is still preferable because it will increase the precision of the estimate for the 
nutrient of interest. Several methods for energy correction are available." In our cross 
sectional analysis of dietary electrolyte intake and blood pressure (Chapter 4.2) we used a 
two-step approach as proposed by Willett and Stampfer." First, total caloric intake was 
used as the independent variable in a linear regression model with the nutrient as the 
dependent variable. The corresponding residuals for each individual were added to the 
expected nutrient intake for the mean energy intake of the study population, resulting in a 
nutrient intake unrelated to total energy. Second, the energy-adjusted nutrient intakes were 
included in the multivariate model. When one is interested also in the effect of total 
energy intake on the outcome, this variable can additionally be included in the model. 
The coefficients for pure nutrient intake and total energy obtained by this method are 
interpretable and have biological significance. 
New research areas 
As pointed out previously in this chapter, specific genetic or physiologica( characteristics 
could be associated with the sensitivity of blood pressure to electrolyte intake. Studies 
especially designed for this purpose are warranted to identify possible honnonal and 
biochemical indicators of sensitivity, or specific genotypes that are likely to show a blood 
pressure response to electrolyte intake. Until now, research in this field has mainly 
focused on sodium. The studies presented in this thesis provide evidence that potassium is 
at least equally important in determining blood pressure and the age-related blood 
pressure rise. The study of potential markers of blood pressure sensitivity to potassium 
intake therefore deserves more attention. 
When markers for susceptibility become available, it is worthwhile to investigate 
whether individuals who are expected to be susceptible show a larger blood pressure 
response to changes in sodium and/or potassium intake than non-susceptibles. It has been 
suggested that age could be one of the modulators of blood pressure response to dietary 
electrolyte intakes. Intervention studies including parallel age groups could further address 
this hypothesis. 
How the susceptibility concept could be implemented in current preventive strategies 
needs further investigation. In addition to the 'high risk' and 'whole population' 
approach, a preventive strategy focusing on susceptible target groups within a population, 
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e.g. school children or nursing home residents, might be considered. In case that 
susceptible subgroups cannot readily be identified within a population, large-scale 
screening for indicators of susceptibility probably has to take place. How this could be 
realised in practice needs further detailed consideration. 
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CHAPTER 6 
SUMMARY 

6 
Summary 
Hypertension is an important risk factor for cardiovascular disease, the leading cause of 
death in Western societies. Blood pressure level in these countries rises sharply from birth 
until old age. In populations with a low intake of sodium and a high intake of potassium, 
the age-related rise in blood pressure is less pronounced and the prevalence of 
hypertension is low. This suggests a possible role of sodium and potassium in determining 
blood pressure. Whereas this hypothesis has been conflrmed in ecologic studies, studies 
within single populations have often failed to demonstrate a relation between intake of 
sodium andlor potassium and blood pressure. One possible explanation could be the fact 
that a population consists of a heterogeneous group of individuals, whose blood pressures 
may respond quite differently to dietary influences. Age could be one of the modulators 
of blood pressure response to electrolyte intake. Tills thesis focuses on two phases in life 
that seem of particular interest in this respect, namely childhood and old age. 
At young age, the hypertensive process is probably initiated and it is worthwhile to 
investigate whether electrolytes could affect the rate of blood pressure change. Chapter 2 
describes the role of salt intake during the first six months of life in detemlining blood 
pressure level 15 years later in life. Blood pressure was measured in a group of 167 
adolescents who had participated in a randomised double blind trial of the effect of a low 
or normal sodium diet on blood pressure in infancy. After adjustment for confounders, 
systolic blood pressure level at follow-up was 3.6 mmHg lower (95% confidence interval 
0.5 - 6.6 mmHg) and diastolic blood pressure level was 2.2 mmHg lower (95% CI -0.2 -
4.5 mmHg) in children who had been assigned to the low sodium diet compared to the 
controls. These findings suggest that sodium intake in infancy could be related to the 
development of hypertension later in life. 
Chapter 3 focuses on sodium and potassium intake in relation to the change in blood 
pressure from childhood into adulthood, using data from a large Dutch population study 
of risk factors for cardiovascular disease (EPOZ). From the study cohort, a group of 596 
children was randomly selected for yearly follow-up of blood pressure and its 
determinants. For 233 children aged 5 to 17 at entry at least six yearly blood pressure 
measurements were performed between 1978 and 1985 (early pbase of the study). For 
167 children at least three additional yearly measurements were available between 1986 
and 1991 (late phase). Mean sodium and potassium intakes were estimated from six 
overnight urine samples that had been collected during the early phase of the study. 
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Individual blood pressure slopes over time (mmHg/year) were calculated by linear 
regression analysis. The relation between mean urinary electrolyte excretions, assessed in 
the early phase, and blood pressure changes in both the early and late phase was studied 
(Chapters 3.1 alld 3.2). Sodium was positively associated, and potassium inversely 
associated with blood pressure change in this cohort of children and adolescents. The 
associations with change in blood pressure appeared to be stronger for potassium than for 
sodium in both the early and late phase of the study. This study shows that electrolytes 
may playa role in detemlining blood pressure change at young age. 
At old age, a number of physiological changes occur that may increase the sensitivity 
of blood pressure to an inadequate intake of electrolytes. In Chapter 4 several studies are 
presented on the relation between electrolyte intake and blood pressure in older people. 
Data were obtained from participants of the Rotterdam Study, a population-based study 
among 7,983 residents of a suburb of Rotterdam aged 55 and over. In Chapter 4.1 the 
association of urinary sodium and potassium excretion with blood pressure was studied in 
1,006 subjects who were not on antihypertensive treatment. Findings were adjusted for 
age, sex, and body mass index. An independent inverse association of urinary potassium 
excretion with blood pressure was observed. An increase of 100 mmol in potassium 
excretion was related to a 9.4 mmHg (95% CI 2.2 - 16.5 JrunHg) lower systolic blood 
pressure, and a 4.9 rrunHg (95% CI 1.1 - 8.7 mmHg) lower diastolic blood pressure after 
adjustment for sodium excretion. A weak positive association was observed for sodium 
after adjustment for potassium excretion: a 100 mmol increase in urinary sodium was 
associated with a 2.2 mmHg (95% CI -0.1 - 4.5 mmHg) higher systolic, and a 0.8 mmHg 
(95% CI -0.4 - 2.0 mmHg) higher diastolic blood pressure level. In Chapter 4.2, dietary 
intakes of potassium, magnesium, and calcium as assessed by a semiquantitative food 
frequency questionnaire were studied in relation to blood pressure in 3,239 subjects who 
were not on antihypertensive treatment. Findings were adjusted for age, sex, body mass 
index, alcohol intake, and total energy intake. Dietary intake of potassium and magnesium 
appeared to be inversely and independently related to blood pressure level. Per gram 
increase in potassium intake, a 0.9 mmHg (95% CI -0.2 - 2.1 mmHg) decrease in systolic 
blood pressure, and a 0.8 mmHg (95% CI 0.2 - 1.4 mmHg) decrease in diastolic blood 
pressure was observed. For magnesium, values were 1.2 mmHg (95% CI -0.002 - 2.5 
mmHg) and 1.1 mmHg (95% CI -0.003 - 1.9 mmHg) per 100 mg, respectively. 
Dietary measures to reduce blood pressure may be more effective when the intake of 
several nutrients is changed sinlUltaneously. In a double blind, randomised, multifactorial 
trial we investigated whether moderate sodium restriction combined with an increase in 
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potassium and magnesium intake would reduce blood pressure in older people with mild 
to moderate hypertension. The findings of this trial are presented in Chapter 4.3. Changes 
in mineral intake were achieved by substituting common sodium salt in the diet with a 
low sodium, high potassium, high magnesium mineral salt for six months. Complete 
follow-up was achieved by 97 of the 100 randomised subjects. In subjects who used the 
mineral salt, mean systolic blood pressure during intervention was 7.6 mmHg (95% CI 
4.0 - 11.2 mmHg) lower, and diastolic blood pressure was 3.3 mmHg (95% CI 0.8 - 5.8 
mmHg) lower than in controls who used common salt. After adjustment for change in 
body weight during intervention, values were 8.7 and 3.6 mmHg respectively. The 
compliance with the intervention was satisfactory, which was reflected in a persistent 
difference in 24 hour urinary sodium and potassium excretion between the study groups. 
The blood lipid profile was not adversely affected by the intervention with the mineral 
salt (Chapter 4.4). 
In Chapter 5 the development of blood pressure during life and the role of electrolyte 
intake in determining blood pressure level and rise are described. This is followed by a 
discussion of intervention approaches, with a special focus on blood pressure sensitivity to 
electrolyte intake. In the next part of the discussion, methodological aspects of research 
into blood pressure and nutrient intake, and the implications of the findings for public 
health, are considered. Finally, some directions for future research in this field are 
delineated. 
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SAMENV ATTING 

7 
Samenvatting 
Hypertensie is een belangrijke risicofactor voor hart- en vaatziekte, de meest 
voorkomende doodsoorzaak in westerse samenievingen. In deze Ianden wordt een sterke 
bloeddrukstijging waargenomen met de Ieeftijd. Bij 'primitieve' volkeren met een Iage 
natrium- en een hoge kaliuminneming is deze bloeddrukstijging minder uitgesproken en is 
de prevalentie van hypertensie Iaag. Dit suggereert een mogelijk effect van natrium en 
kalium in de voeding op de bloeddruk. Deze hypothese is in ecologisch onderzoek 
bevestigd, maar epidemiologische onderzoeken bimlell bevolkingsgroepen kunnen vaak 
geen verband tussen de inneming van natrium enlof kalium en de bloeddruk aantonen. 
Ben van de mogelijke verIdaringen zou kunnen zijn dat personen binnen een bevolking 
sterke onderlinge verschillen vertonen in bloeddrukgevoeligheid voor bepaalde nutrienten. 
De Ieeftijd is mogelijk een van de factoren die van invloed zijn op deze gevoeligheid. De 
onderzoeken beschreven in dit proefschrift zijn uitgevoerd binnen twee specifieke 
Ieeftijdsgroepen die interessant lijken in dit opzicht, namelijk kinderen en ouderen. 
Reeds op jonge Ieeftijd wordt een bloeddrukstijging ingezet die mogelijk Ieidt tot 
hypertensie. Het is daarom zinvol om te onderzoeken of inneming van elektrolyten de 
bloeddrukverandering vroeg in het Ieven beinvloedt. Het onderzoek beschreven in 
Hoojdsluk 2 richt zieh op de relatie tussen de inneming van natrium tijdens de eerste 
Ievensmaanden en de bloeddruk 15 jaar later. Hiertoe werd de bloeddruk gemeten bij 167 
adolescenten die in 1980 deeigenomen hadden aan een gerandomiseerde studie bij 
zuigelingen naar het effect van zoutarme voeding op de bloeddruk. Na correctie voor 
verstorende variabelen was de systolisehe bloeddruk op 15-jarige Ieeftijd 3,6 nunHg lager 
(95 % betrouwbaarheidsinterval 0,5 - 6,6 nunHg) en de diastolische bloeddruk 2,2 nunHg 
lager (95% BI -0,2 - 4,5 mmHg) bij adolescenten die ais zuigeling zoutarme voeding 
hadden ontvangen vergeleken met controlepersonen die normale voeding hadden 
ontvangen. Deze bevinding suggereert dat de inneming van natrium tijdens de eerste 
Ievensmaanden bij zou kunnen dragen aan het ontstaan van hoge bloeddruk op latere 
Ieeftijd. Hoojdsluk 3 rieht zieh op de inneming van natrium en kalium in relatie tot de 
bloeddrukverandering tijdens de jeugd. De gegevens zijn verzameld in een 
vervolgonderzoek bij een willekeurige groep van 596 kinderen die deel uitmaakten van 
het cohort van het Epidemiologiseh Preventief Onderzoek Zoetermeer (EPOZ). Bij 233 
kinderen in de Ieeftjd van 5 tot 17 jaar werden tenminste zes jaarlijkse bloeddrukmetingen 
verricht tussen 1978 en 1985 ("vroege fase"). Bij 167 kinderen uit dit cohort werden nog 
minstens drie extra jaarlijkse metingen verrieht in de periode van 1986 tot 1991 ("late 
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fase"). De gemiddelde inneming van natrium en kalium gedurende de onderzoeksperiode 
werd geschat uit zes overnachtsurines die verzame!d werden in de vroege fase van het 
onderzoek. Met behulp van lineaire regressie-analyse werden individuele bloeddruk-
veranderingen over de tijd (mmHg/jaar) bepaald. De relatie tussen de uitscheiding van 
elektrolyten en bloeddrukverandering in de vroege en late fase van het onderzoek staat 
beschreven in de HoojdsllIkkell 3.1 ell 3.2. Voor natrium werd een positief verband en 
voor kalium een negatief verband met de bloeddrukverandering waargenomen. Het 
verband was sterker voor kalium dan VODr natrium, zowe! in de vroege als in de late fase 
van het onderzoek. De resultaten van dit onderzoek suggereren dat elektrolyten de 
bloeddrukstijging tijdens de jeugd kunnen beinvloeden. 
Op oudere leeftijd treden er verschillende fysiologische veranderingen in het lichaam op 
die de gevoeligheid van de bloeddruk voor een inadequate inneming van elektrolyten 
kunnen verhogen. Hoojdstllk 4 laat de resultaten zien van verschillende onderzoeken naar 
de relatie tussen inneming van elektrolyten en de bloeddruk bij ouderen. De gegevens zijn 
verkregen van deelnemers aan het Erasmus Rotterdam Gezondheid en Ouderen onderzoek 
(ERGO), een bevolkingsonderzoek bij 7.983 mannen en vrouwen van 55 jaar en ouder in 
de wijk Onunoord in Rotterdam. In het onderzoek dat beschreven wordt in HoojdsllIk 4.1 
werd het verband tussen de natrium- en kaliumuitscheiding in de urine en de bloeddruk 
bestudeerd bij 1.006 ouderen. De bevindingen zijn gecorrigeerd voor leeftijd, geslacht en 
Quetelet-index. Ben onafhankelijk omgekeerd verband tussen kalium en de bloeddruk 
werd waargenomen, waarbij een 100 nunol toename in kaliumuitscheiding gepaard ging 
met een 9,4 mmHg (95% BI 2,2 - 16,5 mmHg) lagere systolische en een 4,9 mmHg 
(95 % BI 1,1 - 8,7 llullHg) lagere diastolische bloeddruk na correctie voor natrium-
uitscheiding. Ben zwak direct verband tussen natriumuitscheiding en bloeddrukniveau 
werd waargenomen na correctie voor kaliumuitscheiding, waarbij een 100 mmol hogere 
natriumuitscheiding gepaard ging met een 2,2 mmHg (95% BI -0,1 - 4,5 mmHg) hogere 
systolische en een 0,8 nmlHg (95% BI -0,4 - 2,0 nunHg) hogere diastolische bloeddruk. 
In het onderzoek vermeld in Hoojdstllk 4.2 werd de inneming van kalium, magnesium en 
calcium (gemeten met een voedingsvragenlijst) bestudeerd in relatie tot de bloeddruk bij 
3.239 auderen. De bevindingen zijn gecorrigeerd voor leeftijd, geslacht, Quetelet-index, 
alcoholgebruik en totale energie-inneming. De inneming van kalium en magnesium was 
omgekeerd gerelateerd aan de bloeddruk. Per gram toename in kaliuminneming werd een 
0,9 nunHg (95% BI -0,2 - 2,1 mmHg) lagere systolische en een 0,8 mmHg (95% BI 0,2 
- 1,4 mmHg) lagere diastolische bloeddruk waargenomen. Voor magnesium bedroegen 
deze waarden respectievelijk 1,2 nunHg (95% BI -0,002 - 2,5 11llnHg) en 1,1 mmHg 
116 
Samellmttillg 
(95 % Bl -0,003 - 1,9 mmHg) per 100 mg toename. 
Veranderingen in de voeding om de bloeddruk te verlagen zouden meer effect kunnen 
hebben wanneer niet de inneming van een, maar van meerdere nutrienten gelijktijdig 
belnvloed wordt. In een dubbelblind, gerandomiseerd, multifactorieel onderzoek, 
beschreven in Hoojds/uk 4.3, werd onderzocht of matige natriumbeperking gecombineerd 
met een matige toename van de kalium- en magnesiuminneming de bloeddruk zou kunnen 
verlagen bij ouderen met lichte tot matige hypertensie. De verandering in de inneming 
van mineralen werd bereikt door gewoon keukenzout in de voeding gedurende zes 
maanden te vervangen door een mineraalzout met een verlaagd natrium- en een verhoogd 
kalium- en magnesiumgehalte. Er werden 100 deelnemers in het onderzoek opgenomen, 
waarvan 97 personen het gehele onderzoek afrondden. Bij de deelnemers die het 
mineraalzout gebruikten was de gemiddelde systolische bloeddruk tijdens de 
onderzoeksperiode 7,6 nunHg (95% Bl 4,0 - 11,2 nunHg) lager en de diastolische 
bloeddruk 3,3 nunHg (95% BI 0,8 - 5,8 ImnHg) lager in vergelijking met de 
controlegroep die gewoon zaut gebruikte. Na correctie voor verschillen in 
gewichtsverandering tijdens het onderzoek bedroegen deze waarden respectievelijk 8,7 en 
3,6 mmHg. Het consistente verschiI in natrium- en kaliumuitscheiding in de urine tussen 
de twee groepen gedurende de gehele onderzoeksperiode wees op een goede 
"therapietrouw". Het lipidenprofiel in het bloed werd niet ongunstig belnvloed door de 
interventie met het mineraalzout (Hoofdslllk 4.4). 
In Hoojdslllk 5 wordt de bloeddrukontwikkeling tijdens het leven en de invloed van 
elektrolyten op de bloeddruk beschreven. Vervolgens worden mogelijkbeden voor 
interventie aangegeven, waarbij speciale aandacht wordt besteed aan eventnele inter-
individuele verschillen in bloeddrukgevoeligheid voor elektrolyten. Daarna worden enkele 
methodologische aspecten belicht die aan de orde kwamen in de hierboven beschreven 
onderzoeken, gevolgd door enkele suggesties voor vervolgonderzoek. 
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